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 Breast cancer is the most common cancer among American women. One in eight 
women will be diagnosed with breast cancer during her lifetime. Essentially all breast 
cancer treatment involves surgery. The two most generally performed surgical treatments 
for breast cancer are breast conservation therapy and mastectomy followed by breast 
reconstruction. Breast reconstructive surgery is an important component of the breast 
cancer treatment process.  
 The aesthetic outcome of breast cancer treatment is a critical factor in breast cancer 
survivors’ quality of life. Aesthetics is a general term that refers to physical 
characteristics such as symmetry and proportion. Currently, physicians, patients, or other 
observers evaluate breast aesthetics in a subjective, qualitative manner. However, such 
assessments are typically based on vaguely defined rating scales that have low intra- and 
 viii 
inter-observer agreement. Their qualitative nature also restricts the analyses that can be 
performed. Quantitative, objective measures with high reliability are needed to 
meaningfully relate patient and surgical variables to aesthetic outcomes and to compare 
the outcomes of different kinds of breast cancer treatments (e.g., reconstruction 
procedures). I postulated that quantitative measures of breast aesthetic properties can be 
designed using clinical photographs. In this dissertation, I have designed algorithms to 
compute objective, quantitative, reproducible measures of breast aesthetics. I have 
evaluated the algorithms for computing objective measures of breast aesthetic properties 
such as ptosis and surgical scars from clinical photographs. A preliminary observer rating 
scale of 11 symmetry ratings items, 14 individual breast ratings items, and a global rating 
on overall appearance before and after the entire rating items was proposed. Eye-tracking 
technology was used to understand how plastic surgeons assess breast aesthetics by 
recording their gaze path while they rate breast anatomy on clinical photographs. In 
addition to these design and evaluation tasks, I also have used the objective measures to 
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Chapter 1: INTRODUCTION 
1.1 STATEMENT OF THE PROBLEM 
Breast cancer is the most common cancer among American women. One in eight 
women will be diagnosed with breast cancer during her lifetime. It is predicted that in 
2007, there will be 176,295 new cases diagnosed [1]. Improved screening and treatment 
methods have increased the breast cancer survival rate so that the majority of women 
with breast cancer with localized, early stage disease can be cured when diagnosed early. 
Essentially all breast cancer treatment involves surgery. Breast cancer survivors face a 
myriad of choices to be made with the assistance of their multi-disciplinary breast care 
team. They must make decisions about surgical, radiation, chemotherapy, and endocrine 
therapy options. They must weigh concerns about survival, recurrence, co-morbidities, 
pain, and sexuality. They must confront these issues with incomplete and, at times, 
contradictory information. In addition to continuing to strive to improve detection and 
survival rates, more work is needed on issues that influence the quality of breast cancer 
survivors’ lives.  
The two most generally performed surgical treatments for breast cancer are breast 
conservation therapy and mastectomy followed by breast reconstruction. Mastectomy 
followed by breast reconstruction is a common form of breast cancer treatment for the 
patient who is in advanced stages or has contraindications to radiotherapy [2, 3]. The 
American Society of Plastic Surgeons (ASPS) estimates that approximately 56,000 breast 
reconstructive surgeries were performed in the US in 2006 [4]. Reconstruction can help 
breast cancer survivors regain their quality of life by restoring physical balance and 
helping them carry out their daily lives without being constantly reminded that they are 
cancer patients. Consequently, insurance providers are required to provide coverage for 
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all stages of breast reconstruction under the Women’s Health and Cancer Rights Act of 
1998 (P.L. 105-277). However, while the law requires insurance companies to provide 
breast reconstruction, it doesn’t specify the kind of reconstruction that must be done. 
Healthcare providers, patients, the insurance industry, and the government all want to 
quantitatively assess the outcomes of breast reconstruction surgery in order to establish 
clinical guidelines and help breast cancer survivors make informed choices about their 
treatment options. A system for objective assessment is also needed in order to set 
charges (financial compensations) for different reconstructive procedures. Adequate 
measures of surgical outcome are important to protect patients’ health and well-being. 
Aesthetics refers to physical characteristics of the breasts, such as shape, flow, 
ptosis, and symmetry [5]. Accurate measurement of breast aesthetics is crucial for 
investigating the variables that affect the outcomes of breast reconstruction as well as 
other breast cancer treatments. Approaches to measuring breast aesthetics include 
subjective assessment by human observers [6-46], measurements on the patient 
(anthropometry) [8, 9, 12, 14-18, 23, 28, 47-50], measurements on photographs 
(photogrammetry) [9, 14, 26, 51-53], and measurements using three-dimensional images 
(stereophotogrammetry) [54-58]. Currently, physicians, patients, or other observers 
evaluate breast aesthetics in a subjective, qualitative manner. However, such assessments 
are typically based on vaguely defined rating scales that have low intra- and inter- 
observer agreement. Their qualitative nature also restricts the analyses that can be 
performed. Quantitative, objective measures with high reliability are needed to 
meaningfully relate patient and surgical variables to aesthetic outcomes and to compare 
the outcomes of different kinds of breast cancer treatments (e.g., reconstruction 
procedures). The lack of a generally accepted quantitative method for assessing breast 
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aesthetics limits the effective assessment of the outcomes after breast reconstructive 
surgery.  
In this dissertation, as a step toward objective assessment of aesthetic outcomes of 
breast cancer treatment, I develop and evaluate algorithms for computing objective, 
quantitative, reproducible measures of breast aesthetics factors after breast 
reconstruction.  
 
1.2 OVERVIEW OF THE DISSERTATION 
The dissertation is composed of a total of 7 chapters. Chapter 2 is extended from 
my review paper on assessment of breast aesthetics [59]. Relative to my review paper, 
this chapter has been updated and extended to include the detailed information about 
surgical breast cancer treatment methods including mastectomy followed by 
reconstruction. In Chapter 2, I briefly introduce the current status of breast cancer 
treatment, and the use of mastectomy followed by reconstruction for breast cancer 
treatment. Then, I review the literature on the various breast aesthetics outcome 
assessment methods currently used in four categorized groups: subjective ratings, 
physical measurements, photographic measurements, and 3-D measurements.  
In Chapter 3, I propose innovative quantitative, objective measurements of breast 
ptosis based on ratios of distances between fiducial points manually identified in lateral 
and oblique views of clinical photographs. The new objective measures were compared 
to ratings on a subjective scale made by three experienced clinical observers. Intra- and 
inter-observer variability of the new objective measures and subjective ratings were 
investigated. In this study I found that novice observers could reliably locate the required 
fiducial points as compared to the identifications made by clinical observers. Moreover, 
both novices and clinical observers demonstrated low variability in repeated marking of 
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fiducial points at different time points. Over all there was good agreement between the 
novice and clinical observers, but some differences were seen. 
In Chapter 4, I compare color measurements obtained by clinical digital 
photography to those from a standard colorimeter. Experimental conditions were 
controlled by performing measurements on artificial scars created by a makeup artist 
(TC). The colorimeter measurements of the artificial scars were compared to those 
reported in the literature for real scars in order to confirm the validity of this approach. 
Agreement in photographic and colorimeter measurements was statistically analyzed 
using the hypothesis test for equivalence, the intraclass correlation coefficient (ICC), and 
the Bland-Altman method. I found that photography can be used in place of a colorimeter 
for measuring color properties of skin in a controlled setting. I also demonstrated that 
artificial scars created by a makeup artist under the guidance of a surgeon exhibit color 
properties consistent with real scars. 
In Chapter 5, I present results on using clinical photographs for the assessment of 
linear breast surgical scars. Digital clinical photographs were used to assess quantitative, 
objective measurements of breast surgical scars based on color intensity image analysis 
and area measurements. We demonstrate that the new objective measures utilizing 
clinical photographs are feasible, effective measurement methods using a hypothesis test 
for equivalence, the ICC coefficient, and Bland-Altman methods. 
In Chapter 6, I propose an observer rating scale of 11 symmetry ratings items, 14 
individual breast ratings items, and a global rating on overall appearance before and after 
the entire rating items were proposed. The observer rating scale was assessed for the 
intra- and inter-observer variability against using rating data collected by reconstructive 
surgeons not involved in designing the scale. 
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In Chapter 7, I describe eye-data collected from two plastic surgeons who viewed 
clinical photographs of women who underwent breast reconstruction. Mean dwell time 
across rating items, patients, and observers were compared. The relationships between the 
eye-position analyses and the surgeons’ observer ratings were also analyzed. Some 
consistent patterns in dwell time were also seen across observers and cases. For example, 
both surgeons spent more time looking at the AP views than at the lateral and oblique 
views. This study demonstrated that eye-tracking analysis can help us understand how 
plastic surgeons assess breast aesthetics by using eye-tracking technology to record their 
gaze path while they rate breast anatomy on clinical photographs.  
In Chapter 8, I summarize my findings and suggest improvement for more 
effective outcome assessment method using photographs or other types of imaging 
techniques.  
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Chapter 2: BACKGROUND 
 
Contribution and publication: the study in this chapter will be published in  
1. M. S. Kim, J. C. Sbalchiero, G. P. Reece, M. J. Miller, E. K. Beahm, and M. K. 
Markey, "Assessment of Breast Aesthetics," Plastic & Reconstructive Surgery, in press 
2007. 
2.1 BREAST RECONSTRUCTIVE PROCEDURES 
2.1.1 Mastectomy 
Mastectomy is a surgical cancer treatment procedure, where not only the known 
tumor but also some of the surrounding breast skin and tissue are removed to ensure that 
all cancer cells are removed. There are different forms of mastectomies that a patient may 
undergo depending on her cancer status: simple mastectomy, modified radical 




(a)                    (b)                   (c) 
Figure 2.1: Example illustrations of partial mastectomy. (a) The tumor in the figure's 
right breast is indicated by the black dot. (b) The breast segment containing the tumor is 
removed, and the opposite breast is reduced to match. (c) The remaining breast tissue is 
then reshaped into a smaller breast. (Reprinted, by permission, from Reece GP. Breast 
reconstruction guide for patients: The well-informed patient guide to breast 
reconstruction, p 93, Figure 21.1. © 2002 by The University of Texas M. D. Anderson 
Cancer Center, Houston) 
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The difference between the mastectomy types is the amount of breast tissue 
removed during the procedure. For example, the nipple, areola, minimal breast skin, and 
all breast tissue are removed in simple mastectomy; on the other hand, the nipple, areola, 
and entire breast gland are removed, but all uninvolved breast skin is preserved in skin-
sparing mastectomy. Variations of the mastectomy such as modified radical mastectomy 
involves removal of the nipple, areola, some breast skin, the breast tissue under the breast 
skin, and most of the lymph nodes in the axilla [3, 60-62]. 
 
2.1.2 Breast reconstruction 
For women who must undergo mastectomy, breast reconstruction is a critical part 
of care after breast cancer. Breast reconstruction improves many important psychological 
and aesthetic benefits by physically restoring the breast or the portion of the breast 
removed, and helps many women to return to the life without reminding them of that they 
were breast cancer patients. Breast reconstruction with current technology, however, does 
not fully restore woman’s body as it was before the mastectomy was performed. 
Reconstructed breast that looks very natural will not restore the partial sensation even 
though they may look and move naturally as natural breast does: therefore, successful 
breast reconstruction will make women much closer to their original physical and 
psychological state than women who have not had one.  
A woman may undergo either delayed or immediate breast reconstruction 
according to her risk of cancer recurrence after mastectomy. While immediate 
reconstruction typically has a better aesthetic outcome, a patient has to undergo delayed 
reconstruction if irradiation is to follow mastectomy since radiotherapy can increase 
complications after surgery [63, 64].  
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Decisions about reconstructive surgery will depend on many factors such as: 
patient’s overall health, stage of breast cancer, size of breast, amount of breast tissue, and 
personal preference. Two basic types of breast reconstructions are performed: implant-
based, where artificial material is replaced with missing breast and tissue-based, where 
living material, mainly skin and fat from patient's own body are used [5].  
In implant-based reconstruction, symmetry, one of the most important aesthetic 
factors, is easier to achieve for bilateral reconstruction rather than for unilateral 
reconstruction. However, an additional procedure may be necessary for unaffected breast, 
called mastopexy (breast lift) to obtain symmetry between breasts and the created 
symmetry tends to be temporary since the natural breast becomes more ptotic (breast 
droopiness) with time. Moreover, a breast reconstructed with an implant usually does not 
have natural flow (the upper mound becomes convex unlike natural breast which is 
concave) [65]. 
The main advantage of tissue-based reconstruction is that affected breast will 
behave like a real breast (weight, natural ptosis, and feel). Moreover, the symmetry 
normally lasts longer compared to that of implant-based reconstruction. There are three 
most popular tissue-based reconstructions to be discussed: LD (latissimus dorsi), TRAM 
(transverse rectus abdominis myocutaneous), and DIEP (deep inferior epigastric 






   
     (a)                             (b) 
Figure 2.2: Illustration of implant-based reconstruction. Cross-section of a breast 
reconstructed using an implant shows the position of the implant beneath the muscle and 
skin of the chest wall. (Reprinted, by permission, from Reece GP. Breast reconstruction 
guide for patients: The well-informed patient guide to breast reconstruction, p 16-17, 




In LD reconstruction, the flap composed of an elliptical patch of skin that lies 
over the latissimus dorsi muscle along with the muscle are replaced with breast skin when 
the skin was removed during and the breast volume is replaced with a breast implant in 
most cases. Breast implants are less visible in LD procedure than tissue expansion, which 









(a)                    (b)                   (c) 
Figure 2.3: Illustration of reconstruction with latissmus dorsi (LD) muscle flap. (a) The 
plan for an LD flap shows the elliptical patch of skin overlying the latissimus dorsi 
muscle. (b) The flap is separated from the body except at the point where blood vessels 
enter the muscle. The flap is passed under the axillary skin into the breast area. (c) The 
LD flap is usually used to cover a breast implant. (Reprinted, by permission, from Reece 
GP. Breast reconstruction guide for patients: The well-informed patient guide to breast 
reconstruction, p 28, Figure 7.1. © 2002 by The University of Texas M. D. Anderson 
Cancer Center, Houston) 
 
The transverse rectus abdominis myocutaneous (TRAM) is the most popular 
tissue-based breast reconstruction, and two most common types of techniques are 
performed: TRAM pedicled flap [67-71] and the TRAM free flap [72]. In TRAM, the 
flap either with blood vessels either remained intact or completely severed from the body 
is transferred to the chest via a subcutaneous tunnel to replace the breast skin and volume. 
In TRAM free flap, breast can be shaped effectively with flap over pedicled flap. In both 





              (a)                   (b)                   (c) 
Figure 2.4: Illustration of breast reconstruction with a TRAM pedicled flap. (a) The 
TRAM pedicled flap contains skin, fat, and underlying muscle from the abdomen. This 
illustration shows the plan for the surgery (dotted line) with the muscle and blood vessels 
beneath the skin and fat. (b) The flap is passed through a "tunnel" beneath the upper 
abdominal skin and into the mastectomy area.(c) Blood is supplied from blood vessels in 
the rectus abdominis muscle. The flap is shaped into the new breast. (Reprinted, by 
permission, from Reece GP. Breast reconstruction guide for patients: The well-informed 
patient guide to breast reconstruction, p 34, Figure 8.2. © 2002 by The University of 






          (a)                  (b)                           (c) 
Figure 2.5: Illustration of breast reconstruction with a TRAM free flap. (a) A plan for a 
TRAM free flap shows the muscle and blood vessels. (b) The flap and vessels are 
separated from the body. The blood vessels are preserved for connection to blood vessels 
in the chest or axilla areas. (c) The blood vessels are connected to restore circulation to 
the flap, which is then shaped to form the new breast. (Reprinted, by permission, from 
Reece GP. Breast reconstruction guide for patients: The well-informed patient guide to 
breast reconstruction, p 36, Figure 8.3. © 2002 by The University of Texas M. D. 
Anderson Cancer Center, Houston) 
 
The DIEP free flap is a variation of the TRAM flap and is considered by plastic 
surgeons to be a type of TRAM free flap. The flap therefore consists of skin, fat, and the 




                  (a)                                  (b) 
Figure 2.6: Illustration of breast reconstruction with a TRAM free flap. (a) The standard 
TRAM free flap contains a portion of the rectus abdominis muscle along with skin, fat, 
and blood vessels. (b) In contrast, the DIEP free flap contains no muscle - only skin, fat 
and blood vessels. (Reprinted, by permission, from Reece GP. Breast reconstruction 
guide for patients: The well-informed patient guide to breast reconstruction, p 40, Figure 
9.1. © 2002 by The University of Texas M. D. Anderson Cancer Center, Houston) 
 
2.2 ASSESSMENT OF BREAST AESTHETICS 
The goal of plastic surgery of the breast is to recreate a natural appearance that is 
satisfying to the patient. Aesthetic breast surgery is intended to alter the appearance of a 
normal breast to more closely approach some preferred aesthetic ideal as understood by 
the patient. Reconstructive breast surgery has the identical purpose but starts with a breast 
considered abnormal in appearance due to a deformity or complete absence as following 
total mastectomy. Despite the fundamental nature of this outcome, breast aesthetics is 
poorly understood and difficult to measure. In this context, aesthetics refers to visible 
physical characteristics of the breast that determine the subjective evaluation of overall 
appearance [5]. Relevant factors include breast size, shape, proportion, ptosis, symmetry, 
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skin quality, and nipple location [77-81]. Although these are generally understood as 
important, there remains no objective, quantifiable determinants of breast aesthetics that 
are universally acknowledged [82]. This absence of standards has several undesirable 
consequences. It makes it difficult to compare outcomes of different surgical techniques. 
It also fosters discord when a discrepancy exists between the aesthetic impression of the 
plastic surgeon and the patient. Significantly different perceptions of body image 
regarding attractiveness, natural, and ideal breast shape remain among patient and plastic 
surgeon groups [83, 84]. The relationship between physical appearance and psychological 
body image is a central aspect of a patient’s quality of life, and study of this relationship 
can only be achieved through appropriate aesthetic outcome assessment [85-90]. It is 
therefore essential to characterize the elements of aesthetic breast appearance in order to 
make meaningful comparisons between competing surgical techniques, to adequately 
inform patients of realistic outcomes, and to make systematic advances in treatment. 
Objective measurement will reduce the gaps between the plastic surgeon’s surgical 
success and patient’s desire. In addition, objective measures are crucial for documenting 
to third party payers and health policy analysts the clinical value of costly techniques 
such as autologous breast reconstruction [81, 91, 92].  
Current approaches to breast aesthetic measurements include: subjective 
assessments by human observers, measurements on the patient’s body (anthropometry), 
measurements on photographs (photogrammetry), and measurements using three-
dimensional images of the breasts.  
 
2.2.1 Observer rating scales 
Breast aesthetics is commonly assessed by visual assessment, which typically 
employs a crude gradation scale and is inherently subjective and qualitative (Table 2.1). 
 15 
Substantial variability has been reported in the use of common scales of four gradations 
of aesthetic change 
! 
(" = 0.21# 0.31) [93, 94]. Likewise, the reported reliability of visual 
analogue scales is unacceptable 
! 
(" = 0.13# 0.15)[94].  
It has been argued that global scales suffer from vague terminology and that more 
reliable aesthetic assessments will require separate measurements of individual factors. In 
particular, subscales with more explicit criteria for each aesthetic component (e.g., 
volume, contour) have been recommended [94]. However, substantial observer variability 
was still reported when such subscales were employed (
! 
" = 0.19 # 0.63) [94]. Similarly, 
subscales of four gradations have been proposed for rating the difference between treated 
and untreated breasts in terms of size, shape, skin color and firmness, and the visibility of 
surgical scar, but low to moderate reliability were again reported (
! 
" = 0.24 # 0.40) [95].  
It is also noteworthy that there is a lack of concordance between different 
observer groups [96-98]. Sneeuw et al. reported that patients demonstrated significantly 
greater variation (
! 
" < 0.10) in aesthetic scoring compared to professionals (
! 
" = 0.64) 
using global 4-point subscales, suggesting that accurate measures may require that patient 










Table 2.1: Observer Rating Scales Assessment. BCT and BRC denote breast conservation 
therapy and breast reconstruction, respectively. 
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Reported higher intra-rater 
agreement but lower inter-rater 
agreements between ratings by 


























Reported better internal 
consistency and more reliability 
of ratings by patients evaluating 
their own results; Ratings by 
surgeons were not as internally 
consistent and reproducible. 




In contrast, a study by Cohen et al., which employed a global 5-point scale, 
reported greater internal consistency among patients (
! 
Chronbach " = 0.92) compared to 
medical professionals (
! 
Chronbach " = 0.74 # 0.89) assessment of the breast aesthetic 
appearance using photographs of 36 autologous breast reconstruction patients. There was 
 17 
poor inter-observer agreement among surgeons 
! 
" = 0.0 # 0.39( ) and a weak correlation 
between surgeons and patients 
! 
Spearman " = 0.36 # 0.53( )  [100]. 
These studies highlight two major disadvantages of observer rating scales. The 
first is variable internal consistency and reproducibility as demonstrated by low intra- and 
inter- observer agreement (Table 2.1). In an attempt to overcome this problem, data 
averaged from a panel rather than individual evaluators are often employed, but this 
approach is time and labor intensive. Also, calculating an average can reduce variability 
but not improve accuracy. The second problem is the lack of a standardized, explicit scale 
for analyzing aesthetic outcome. A crude ordinal scale with four or five categories is 
imprecise for identifying individual aesthetic elements. Quantitative, objective measures 
with high reliability are needed in order to meaningfully relate patient and surgical 
variables to aesthetic outcomes. 
 
2.2.2 Physical measurements 
Anthropometry is based on linear measurements between surface landmarks such 
as the sternal notch, nipple, inframammary fold, and lowest point of the breast mound 
(Table 2.2). Penn’s approach of defining nipple-to-sternal notch and midclavicular point 
distances of “aesthetically perfect” breasts of 20 women gained broad attention and has 
been adopted by many as normative [101]. In a similar attempt to establish normal 
values, the distances between fiducial points were computed in 66 women in whom one-





Table 2.2: Physical Measurements. 





Linear measurements between fiducial points were 




66 patients with 
breast hypertrophy, 
ptosis, or both 






40 patients with 
breast asymmetry  
 
Weak correlation was reported for nipple position 
relative to sternal notch, midline, and axilla in 




50 women with 
aesthetically perfect 
breasts 
Of 22 linear measurement performed, nine 
measurements were shown to have significant 




151 women (100 
normal breasts and 51 
BCT patients) 
Reported a correlation between the difference of the 
Breast Compliance Evaluation (BCE) measure of 












Breast symmetry was assessed by three linear 
measurements between fiducial points and the 











Reported correlation of patient characteristics (age, 
height, weight, Body Mass Index (BMI)) and breast 
proportions and significant positive correlations 
between age and areola-breast proportion. 
 
In another study, the same group measured the symmetry of 40 patients by 
computing differences between the right and left breast. They studied the relationship 
between observer ratings and linear measurements with scatter diagrams of linear 
measurements and aesthetic score [105]. “Aesthetically perfect breasts” was defined as a 
breast shape for which no aesthetic procedure would be indicated. The problem with this 
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definition is that different surgeons have different notions of when an aesthetic procedure 
is indicated. For example, in general, European Plastic Surgeons feel that what American 
Plastic Surgeons consider to be the “ideal breast” is really too large and they would 
recommend a breast reduction. Twenty two linear measurements were designed and 
compared to the results with those of Penn [101] and Smith [102]. Nine of the measures 
were shown to have statistically significant correlation (
! 
Pearson r = 0.459 " 0.592) with 
breast volume [49].  
Symmetry has typically been determined by calculating the difference in 
measured distances on the breast mound and nipple/areola complex. A good example of 
measuring the symmetry is demonstrated in the Breast Compliance Evaluation (BCE) 
method, where the distance from the point of mid-clavicle to the inframammary fold 
through the center of the nipple was measured in both supine and erect positions using a 
tape measure. Compliance was calculated from controls and cancer patients by 
determining the difference in the measures between the two positions and the aesthetic 
outcome of treated breasts was evaluated by comparing the difference between the 
compliances of the two breasts. Correlation between BCE and satisfactory aesthetic 
outcomes was reported, but the reliability of the measurement was not clear [106]. 
Combination of physical measurement with observer ratings was attempted to measure 
the symmetry by making three measurements on 72 patients with asymmetrical breasts, 
but the correlation between the measures and reproducibility was not analyzed [107]. 
Areola diameter in addition to the distances between sternal notch-to-nipple, and nipple-
to-inframammary fold were measured, and compared with the observer ratings for 
patients with developmental asymmetry [108]. 
Another study computed the distances between the nipple and the borders of the 
breast to calculate the nipple-areola-breast proportion and showed the correlation of 
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patient characteristics (age, height, weight, Body Mass Index) and breast proportions. 
Significant positive linear correlations between age and areola-breast proportion 
(
! 
Pearson r = 0.47 ) were reported and areola-nipple proportion was shown to be 
significantly larger in higher ptosis grades [109].  
Anthropometry can be a useful tool for quantifying aesthetic outcomes. However, 
this method has several pragmatic limitations. Fundamental parameters such as breast 
projection are difficult to evaluate because of the curvature of the underlying chest wall 
and mobility of subcutaneous tissue. In addition, anthropometry can be complicated and 
time intensive, making it impractical for routine use. Studies of linear measurements on a 
patient must be done prospectively and they require an extra intervention, which tends to 
keep the number of subjects low. It is not feasible to make a large number of 
measurements on each subject. If a particular measurement doesn’t prove valuable, one 
can’t retrospectively try a different one. To prove the validity of a specific measurement, 
studies across multiple institutions with multiple observers are needed, which are costly. 
The relationships to observer rating scales is unclear [105, 107, 108, 110, 111].  For 
these reasons, direct measurements have had limited utility in routine clinical practice 
and are not generally performed. 
 
2.2.3 Photographic measurements 
The value of photographs for observer rating assessment of breast aesthetics was 
confirmed by comparable results for assessments based on photographs compared to 
physical examination [26]. Moreover, prints produced from digital images, digital images 
displayed on computer monitor, or conventional photographs have been shown to be 
acceptable to observers for observer rating assessment of breast aesthetics [112].  
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Table 2.3: Photographic Measurements.  















Patient & clear 







to 27 BCT 
patients 
BRA was significantly greater for 
breast cancer patients than for the 
control groups. BRA calculations 

















Significant correlations between 
BRA and the observer rating scores 
were found.  Increased BRA 


























Found a significant correlation 
between pBRA and observer rating 
assessment at a three-year follow-up 



























A 3-member panel, comprised of 
either health care professionals or 
patients, assessed the images. 
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The variability in the objective 
measurements due to intra- and inter- 
observer variability in marking 
fiducial points was shown to be 
equivalent to less than one point on 




Rather than simply obtaining observer ratings based on photographs, several 
investigators [26, 40, 114-118] describe measurements calculated on digital/digitized 
photographs (Table 2.3). This approach has yielded encouraging results, but there are 
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limitations to the reported studies. The majority of these have only been reported in 
breast cancer patients undergoing breast conservation therapy (BCT) and those have 
limited utility for full aesthetic assessment. They rely on many of the same fiducial points 
described above for anthropometry, but some anatomical landmarks may not be visible in 
photographs (e.g., the inframammary fold). They also rely heavily on the anatomy of the 
nipple/areola complex, which may not reflect independent features of the breast mound. 
Finally, they typically involve only a single anterior-posterior (AP) photograph for each 
patient.  
The Breast Retraction Assessment (BRA) has been successfully applied in the 
assessment of asymmetry [117]. The BRA measure is the Euclidean distance between 
right and left nipples. Early studies employed the aid of a clear acrylic sheet marked as a 
grid with the patient behind the screen, which is functionally equivalent to calculating 
distances on a digitized/digital photograph. BRA was compared between normal 
volunteer and 27 BCT patients, and the measure was significantly greater for the breast 
cancer patients than for the control group. BRA calculations correlated with the size of 
resection [117]. 
Van Limbergen et al. [114, 115] calculated four measurements on AP 
photographs: the vertical distance from the level of the sternal notch to the nipple (A), the 
vertical distance from the level of sternal notch to the inferior pole of the breast (I), the 
horizontal distance from the midline to the nipple (M), and the horizontal distance from 
the midline to the lateral breast contour (L). The authors used the differences in each 




Figure 2.7: Breast Retraction Assessment (BRA).  AP view of the patient standing 
behind acrylic grid plate. X- and Y-axes are marked on the photographs and distances 
between nipples are calculated using the grids for calculating BRA.  “Reprinted from 
Publication Pezner, R.D., et al., Breast retraction assessment: an objective evaluation of 
aesthetic results of patients treated conservatively for breast cancer. International Journal 
of Radiation Oncology, Biology, Physics, 1985. 11(3): p. 575-8. with permission from 
Elsevier” 
 
Observer rating assessment by a panel comprised of a surgeon, a radiotherapist, 
and a non-physician was also made from the photographs using a five-point scale and the 
mean panel rating was correlated to the BRA measure. In 142 BCT patients, significant 
correlations between BRA and the Observer rating scores 
(
! 
p = 0.0001: X square test,  Kendall Tau B and Kendall Tau C ) were found with increased 
BRA associated with poorer aesthetic outcome. Since the magnification of clinical 
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photographs is not standardized, they introduced a relative version of the BRA measure 
(pBRA) equal to BRA divided by the distance from the sternal notch to the nipple of the 
untreated breast. Using this measure they found smaller intra- and inter-observer 
variability based on pBRA than on observer rating assessments. They also found a 
significant correlation between pBRA and Observer Rating assessment at a three-year 
follow-up except for those with inferomedially located tumors (
! 
" = 0.24 # 0.53) [115, 
116] (Figure 2.1).  
Some studies have employed a computer program to obtain more consistent 
measurements [118]. Four measurements were calculated on AP images of 148 women 
who underwent BCT. Distances were computed for from each nipple to the contralateral 
nipple, the inferior pole of the breast, the midline, and the sternal notch. A 3-member 
panel comprised of either health care professionals or patients then assessed the images. 
Significant differences were reported in the aesthetic outcome between each method of 
assessment.  
Quantitative and objective measurements of breast ptosis have been designed 
based on ratios of distances between fiducial points manually identified in 
digitized/digital images of oblique and lateral clinical photographs (pre-operative). These 
measures were compared to ratings made using a 4-point scale by Regnault [119]. The 
new objective measures of ptosis showed encouraging levels of concordance with ratings 
made by experienced surgeons using the observer rating scale. The objective measures 
were found to be robust to intra- and inter-observer variability in marking fiducial points, 
including identifications by “novice” observers. The variability in the objective 
measurements due to intra- and inter-observer variability in marking fiducial points was 
shown to be equivalent to less than one point on the observer rating ptosis scale [120].  
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Photogrammetry has advantages over anthropometry. A photograph is more 
efficient and less intrusive for the patient. They create a permanent record from which it 
is possible to make a variety of measurements. Digital/digitized photographs can be 
analyzed using an automated process on a computer, potentially yielding more consistent 
objective results. The disadvantages are that some anatomic landmarks may not be visible 
and the measurements cannot be obtained following the contours of the patient’s body. 
Some studies have reported substantial intra- and inter-observer standard deviation for 
linear measurements on photographs, related primarily to the lack of consistency in the 
manual identification of anatomic landmarks [116]. Consistent guidelines for standard 
photography are critical to obtaining reproducible assessment of aesthetic outcomes from 
one institution to another [121-125]. 
There are commercial software systems for working with digital/digitized 
photographs in plastic surgery, such as Nautilus Plastic DesignerTM (NauSoft LLC, St. 
Louis, MO), MirrorTM software (Canfield Clinical Systems, Fairfield, NJ), and iMARSTM 
software (iMARS Medical Office Management Systems). However, it should be noted 
that most products are focused on data management rather than analysis. Some such 
systems will allow the surgeon to simulate or morph the postoperative result in an artistic 
manner. However, these simulated images are not really representative of the actual 
surgical outcome. 
 
2.2.4 Three-dimensional imaging 
Three-dimensional (3D) imaging (Figure 2.2, Table 2.4) is a recent innovation 
applied to assessing breast appearance. Several technologies such stereophotogrammetry, 
laser scanning, three-dimensional digital photography, and light digitizers are used to 
create 3D images that have advantages in the analysis of human three-dimensional 
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structures [126]. This utilization is well documented in craniofacial and facial plastic 
surgery for aiding in surgical planning, evaluation of facial soft tissue volume changes 
and symmetry, and in objectively assessing the results [126-131] .  
 
 
Figure 2.8: Representative images illustration and measurement capabilities. Left image 
displayed laterally rotated image and co-ordinate axes. Right view displayed using the 
mesh mode and surface of the breast. Breast projection and volume enclosed between the 
base and the surface are quantitatively estimated. Reproduced images by 3dMDtorso 
Imaging System (3-Q, Technologies Ltd., Atlanta, GA). 
 
Three dimensional digital photography systems are capable of non-invasively and 
quickly capturing high-definition 3D images and constructing topographic surface maps 
of the breast that permit accurate evaluation and objective determination of differences in 
volume, surface area, shape, size, contour, and symmetry [57, 127, 132-134]. A single 3D 
image yields more information regarding breast appearance than multiple conventional 
photographs including data regarding some elements of the breast appearance, such as 
volume, that are not available from two-dimensional images [82]. Assessment of the 
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degree of soft-tissue edema following surgery is another important application of 3D 
imaging [57, 135]. 
Breast volume is an extremely useful parameter for the correction of breast 
asymmetry in breast reconstruction. For example, for a patient seeking delayed unilateral 
reconstruction, the calculated volume of the contra-lateral breast could facilitate the 
selection of implant/tissue volume that would provide improved symmetry. Many 
methods have been described to determine breast volume: water displacement, the 
Grossman-Rounder device, thermoplastic casting, biostereometric analysis, and 
radiographic techniques [100, 136-144]. Most of them are inaccurate, time-intensive, or 
expensive. Digital 3D imaging overcomes these limitations, permitting automated 
calculation of breast volume. Both semi-automated [145] and automated image analysis 
[146] methods have been developed for measurement of breast volume from 3D data. 
Once an image is acquired, it is possible to rotate the subject on the computer screen to 
see not only the front and side views, but also at any angle in between [147]. Point-to-
point measurements occur in a tangential arc to the surface topography rather than in 
conventional linear measurements. Thus, volume, surface distance and area are 
ascertained by measurement of soft tissue overlying the bitmap wire frame of the digital 
image. 
 Galdino et al. analyzed 3D images of over 50 patients who underwent breast 
reconstruction out of over 100 patients who underwent 5 types of breast surgeries [57]. 
They used the images to preoperatively estimate the expander and implant volumes and 
decide the type of surgery between TRAM versus DIEP, and to postoperatively assess 





Table 2.4: Three-dimensional Imaging. 
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Difficulty was experienced in the analysis of very 
ptotic breasts, with a tendency to under calculate 
breast volume (contrast with the observation by 
Galdino [57]). Inherent difficulties in consistently 




Kovacs et al. demonstrated that three-dimensional imaging contralateral breast 
volume can be used to estimate volume requirements for breast reconstruction [82]. The 
accuracy and reproducibility of 3D analysis was tested by comparing breast volumes 
calculated from 3D images to actual volumes measured from mastectomy specimens by 
water displacement. Difficulty was experienced in the analysis of very ptotic breasts, with 
a tendency to under calculate breast volume. Variability in volume analysis was 
attributed to difficulties in consistently identifying breast boundaries. A more useful and 
accurate indication for 3D imaging of the breast would be to evaluate longitudinal 
changes in breast size, volume, shape, and surface area by superimposing images over 
time and calculating differences with accuracy [135].  
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Commercially available 3D imaging systems for plastic surgeons include features 
such as morphing operations to alter sizes (such as breast sizing for mammaplasty), and a 
broad range of art tools for simulation of aesthetic alterations on images. Some of the 
popular software systems include 3dMD Breast AnalysisTM (3-Q, Inc., Atlanta, GA) and 
3D Surgeons (Genex Technologies Inc., Kensington, MD). However, as is the case for 
systems for analyzing 2D images, some current products allow unrealistic simulations of 
surgical outcome that are based on very little or no quantitative information on specific 
breast aesthetic parameters (e.g., symmetry). 
Three-dimensional imaging has tremendous potential for analysis of breast 
appearance. The technique does have limitations, particularly for women with large, 
ptotic breasts and patient positional changes do influence measurements. Nevertheless, 
3D systems may offer the most accurate means to quantify numerous elements of breast 
appearance and evaluate changes over time [57, 150]. Further development of this 
technology might yield a variety of useful clinical tools to aid surgical planning, patient 
decision making, and outcomes analysis [82, 147, 150]. 
 
2.3 SUMMARY 
The contemporary goals of breast cancer treatment are not limited to cure but 
include maximizing quality of life. All breast cancer treatment has the potential to 
adversely affect breast appearance and cause morbidity due to deformity. Developing 
objective, quantifiable methods to assess breast appearance is important to understand the 
impact of deformity on patient quality of life, guide selection of current treatments, and 
make rational treatment advances.  
Currently, there is no reliable means to meaningfully assess breast appearance. 
Current methods are plagued with poor reproducibility and are excessively influenced by 
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observer rating interpretations. Those that yield more objective data are based on physical 
measurements, but they are time and labor intensive and generally impractical for routine 
clinical use. A more complete understanding of how these objective measures are related 
to qualitative aesthetic judgments is also needed.  
Aesthetics will always be an elusive outcome due to the variability of culture, 
ethnicity, and personal preferences. Nevertheless, the physical elements that define breast 
appearance do permit objective evaluation and may serve as tools to gain better control 
over aesthetic outcomes. The most important issue in breast reconstruction seems to be 
achieving symmetry with the contralateral breast even when it is not an aesthetically 
pleasing breast. There is a division between anatomic parameters that determine breast 
appearance and the subsequent observer rating judgments related to aesthetics, but these 
are interrelated concepts. Developing tools to more objectively assess the anatomic 
components of breast appearance will contribute to better evaluation of aesthetics. More 
research is needed to develop an evaluation method with high reliability and 
reproducibility that is also practical. A detailed observer rating qualitative scale with 
standardized terminology would improve communication between reconstructive 
surgeons and radiation oncologists. Quantitative calculations based on standardized 
digital/digitized two-dimensional photography could be a reliable and reproducible 
approach that takes advantage of existing, easy access technology. Three-dimensional 
imaging has even greater potential, though more substantial development is needed. 
In the absence of an absolute “gold standard”, a comparative analysis of 
quantitative aesthetic outcome assessment by medical professionals, assessment by 
patients, and degree of patient satisfaction would be useful for identifying factors that 
influence a woman’s quality of life after breast cancer treatment and rehabilitation and as 
a check of the appropriateness of new assessment measures. Highly reliable outcome 
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scales would allow more meaningful comparison of results and effectiveness among 
surgical techniques. They would be applicable not only to breast cancer treatment but to 
all forms of plastic surgery of the breast. 
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Chapter 3: MEASURING PTOSIS FROM CLINICAL 
PHOTOGRAPHS 
Contribution and publication: the study in this chapter was published in the journal of 
1. M. S. Kim, G. P. Reece, M. J. Miller, E. Beahm, E. N. Atkinson, and M. K. Markey, 
"Objective assessment of aesthetic outcomes of breast cancer treatment: measuring ptosis 
from clinical photographs," Computers in Biology and Medicine, vol. 37, pp. 49-59, 
2007. and was presented at the conference  
2. M. S. Kim, G. P. Reece, E. N. Atkinson, and M. K. Markey, "Objective assessment of 
the aesthetic outcomes of breast cancer treatment: measuring ptosis from clinical 
photographs," presented at BECON/BISTIC 2004 Symposium on Biomedical Informatics 
for Clinical Decision Support: a Vision for the 21st Century, Washington D.C., 2004. 
3.1 INTRODUCTION 
An important aesthetic property that has not been addressed by prior 
photogrammetry studies is ptosis. Ptosis of the breast is classified according to the 
relationship between the nipple and the inframammary fold, the crease beneath the breast. 
Unacceptable ptosis occurs when nipple and lower pole of the breast descend lower than 
the level of inframammary fold [15]. Regnault [16] defined four grades of ptosis. A 
patient has no ptosis when the nipple and most of the breast gland is located above the 
level of submammary fold (Grade 0). In first degree or minor ptosis, the nipple is at the 
level of submammary fold and above the lower contour of the breast (Grade 1). Second 
degree or moderate ptosis is when the nipple lies below the fold but above the lower 
contour (Grade 2). Third degree or major ptosis is when the nipple lies at the lower breast 
contour and most of the breast is below the fold (Grade 3). The ptosis scale with example 
photographs is described in Table 3.1 and Figure 3.1. 
In this study, I designed quantitative, objective measurements of breast ptosis 
based on ratios of distances between fiducial points manually identified in lateral and 
oblique views of clinical photographs. The new objective measures were compared to 
ratings on an observer rating scale made by three experienced clinical observers. Intra- 
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and inter-observer variability of the new objective measures and Observer Rating ratings 
were investigated. 
 
Table 3.1: Observer rating ptosis scale based on Regnault [16] and Bostwick [15]. 
Sample images are shown in Figure 3.1. 
Ptosis Grade Definition 
 
0 = None 
 
Nipple and most of gland are above IMF 
 
1 = Minor 
 
Nipple at IMF 
 
2 = Moderate 
 
Nipple is below IMF but above lower contour of breast 
 
3 = Major 
 





Grade 0 Grade 1 Grade 2 Grade 3 
Figure 3.1: Sample images (right lateral view) illustrating the ptosis grades described by 
Regnault [16] and Bostwick [15]. n: nipple point, i: lateral terminus of inframammary 
fold. 
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3.2 MATERIALS AND METHODS 
3.2.1 Datasets 
The patient population for this study was women aged 21 years or older who 
underwent breast reconstruction surgery from January 1, 1990 to June 1, 2003. Anterior-
posterior (AP), right and left lateral, and right and left oblique photographs were digitally 
taken with a Nikon 990 Coolpix or Cannon T90 35mm SLR with 50mm lens and 
digitized with a Nikon LS 2000 or Nikon Super Coolscan 4000ED (1.06) slide digitizer. 
An experienced plastic surgeon (GPR) selected pre-operative images for 52 patients. The 
dataset demonstrates a wide range of breast aesthetic characteristics including size, 
symmetry, ptosis, and projection. 
 
3.2.2 Ptosis: observer rating 
The ptosis of each breast of all 52 patients was rated by three clinical observers 
(GPR, MJM, EKB) independently using a 4-point scale (Table 3.1, Figure 3.1) described 
by Bostwick [15]. All five views of a patient were displayed simultaneously. The 
observer rating assessment was repeated at three time points at least 2 weeks apart. Thus, 
it is unlikely that an observer recalled his/her previous rating. Kappa statistics of observer 
rating scale measures between time points (1st vs. 2nd, 2nd vs. 3rd, and 1st vs. 3rd) were 
analyzed to investigate intra-observer variability. Kappa statistics of the observer rating 
scale measures between clinical observers (GPR vs. MJM, GPR vs. EKB, and MJM vs. 
EKB) were analyzed to investigate inter-observer variability. 
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3.2.3 Fiducial points 
Out of the 52 patients whose names were unknown to any observer, a clinical 
observer (GPR) selected ten patients that illustrate a wide range of aesthetic 
characteristics (size, ptosis, and projection) and ethnicity. Eight observers (three clinical 
(GPR, MJM, EKB) and five novices) marked fiducial points in images of the ten patients 
on three occasions with 5 minutes breaks between assessments. The novice observer 
group was trained to mark fiducial points by a clinical expert (GPR) before the study was 
performed using a separate set of photographs. There were no additional guides or hints 
provided for marking fiducial points during the study. The four fiduical points marked 
were the sternal notch, lateral extent of the inframammary fold, the lowest visible point, 
and the nipple centroid. The sternal notch (s) or jugular notch point is the shallow 
indentation on the superior surface of the manubrium. It is located between two clavicular 
articulations [15, 17]. The inframammary fold is a curvilinear structure which is generally 
hidden behind breast tissue since most women have some degree of ptosis [15]. The 
lateral terminus of the inframammary fold is the endpoint of the inframammary fold (i) 
where it intersects at the chest wall and it is typically visible in the lateral and oblique 
photographs. Therefore, the lateral terminus of the inframammary fold was used as the 
reference point. The lowest visible point (v) of the breast is located at the most inferior 
point of the breast. The centroid of nipple (n) is considered rather than the nipple-areola 
complex since many women have an irregular shaped areolae. The sternal notch (s), 
lateral terminus (i) and the nipple (n) are marked in the oblique views of the right and left 
breasts separately. The nipple (n), the lowest visible point (v), and the lateral terminus (i) 
are marked in the lateral views of the right and left breasts separately. We designed a 
program using MATLAB® (The MathWorks, Natick, MA) to automatically load the 
images and prompt the observer to manually identify locations of the fiducial points. The 
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x- and y- coordinates and the time required per each fiducial point were recorded. We 
studied x- and y- localizations for the fiducial points for both clinical and non-clinical 
observers. Minimum and maximum values of variability of the fiducial points for both 
groups were calculated. 
 
3.2.4 Ptosis: objective measures 
I explored objective, quantitative measures of aesthetic properties computed from 
relative distances between fiducial points. It is not possible to compare absolute distances 
since the magnification of the images was not standardized over the data set images. The 
pixel coordinate system was used since it preserves the unique coordinates for each 
fiducial point when the images are resized. I designed two measures relating to ptosis 
using the oblique and lateral clinical photographs.  
Measure (2.1) is computed from the oblique views of the right and left breasts 
separately (using the proximal breast, which is nearest to observer’s viewpoint). The 
vertical level of the sternal notch (s) is taken to be zero and the vertical displacements of 
the lateral terminus (i) and the nipple (n) are calculated from it. If the nipple is higher 
than the lateral terminus, then by definition there is no ptosis and the value is set to one; 
otherwise, measure (1) is calculated. Values near one indicate little ptosis while values 










Figure 3.2: Measure (3.1) in right oblique view. The level of sternal notch (s) is extended 
with dotted line. The distances between sternal notch (s) to the point of lateral terminus of 
inframammary fold (i) and between the sternal notch (s) to the nipple (n) are indicated 
with arrowed lines. 
 
Measure (3.2) is calculated from the lateral views of the right and left breasts 
separately. The vertical level of the lowest visible point of the breast (v) is taken to be 
zero, and the vertical displacements of the nipple (n) and the lateral terminus (i) are 
calculated from it. If the nipple is higher than the lateral terminus, then by definition there 
is no ptosis and the value is set to one; otherwise, measure (3.2) is calculated. Values near 





                                  (3.2) 
Our objective measures for ptosis as defined above are expected to have values in 
the range from 0 to 1, but the observer rating scale ranges from 0 to 3. Thus, I rescaled 
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our objective measure values to be more similar to the observer rating scales to simplify 
interpretation of our objective measures. For the right and left breast separately of 10 
cases, the observer ratings and objective measures were averaged across the three clinical 
observers (GPR, MJM, EKB) across the three time points. A simple linear regression was 
then used to relate the objective measures to the observer ratings. The regression model 
was used to transform the objective measures of the novice group for same 10 patient 





Figure 3.3: Measure (3.2) in right lateral view. The level of lowest visible point (v) is 
extended with dotted line. The distances between nipple (n) to the lowest visible point (v) 
and between the point of the lateral terminus of inframammary fold (i) to the lowest 
visible point (v) are indicated with arrowed lines. 
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3.3 RESULTS 
3.3.1 Ptosis: observer rating measures 
Kappa statistics of observer rating scale measures between time points (1st vs. 2nd, 
2nd vs. 3rd, and 1st vs. 3rd) and between the three clinical observers (GPR vs. MJM, GPR 
vs. EKB, and MJM vs. EKB) were studied. Kappa results showed good to excellent intra-
observer agreement (0.52 - 0.84). However, the inter-observer agreement varied across 
observers (0.23 - 0.49) and was lower in the case of MJM vs. EKB (0.07 - 0.15). The 
average values of the observer ratings across the three clinical observers for 10 cases 
were used to calibrate our objective, quantitative measures (Table 3.2 and Table 3.3). 
 
Table 3.2: Kappa statistics of observer ratings over the time by three clinical experts. All 
52 patients images were rated for ptosis by three clinical observers (GPR, MJM, & EKB) 
using a 4-point scale (Table 3.1) based on Regnault [16] and Bostwick [15] at three 
points, approximately 2 weeks apart. The amount of time between ratings was chosen to 
minimize the likelihood that the clinical observer would recall his previous ratings. First 




 First vs. Second First vs. Third Second vs. Third 
 GPR   MJM EKB GPR  MJM EKB GPR MJM EKB 
Right Breast 0.64  0.59 0.63 0.67  0.52 0.61 0.78   0.84 0.67 
Left Breast 0.72  0.71 0.59 0.64  0.64 0.62 0.74  0.74 0.66 
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Table 3.3: Kappa statistics of observer ratings across the three clinical experts. All 52 
patients images were rated for ptosis by three clinical observers (GPR, MJM, & EKB) 
using a 4-point scale (Table 3.1) based on Regnault [16] and Bostwick [15] at three 
points, approximately 2 weeks apart. The amount of time between ratings was chosen to 
minimize the likelihood that the clinical observer would recall his previous ratings. GPR 
vs. MJM, GPR vs. EKB, and MJM vs. EKB ratings are compared. 
 
3.3.2 Fiducial point localization 
I studied the variability of the three clinical observers over time, variability 
between the clinical observer group and novice group, and the time required for each 
fiducial points between the clinical observer group and novice group.  
Figure 3.4 illustrates examples of the variability of a clinical observer (GPR) over 
three time points and Figure 3.5 illustrates the variability of three clinical observers 
(GPR, MJM, EKB) for one time point (Table 3.4 and Table 3.5). The clinical observer 
group was especially consistent in marking the locations of the nipples relative to novice 
group. In the oblique view, the maximum standard deviation across time points among all 
patients, both breasts was 1.64 pixels in x and 0.71 pixels in y for the nipples. In the 
lateral view, the maximum standard deviation across time points among all patients, both 
breasts was 1.27 pixels in x and 1.41 pixels in y for the nipples. The variability across 
time points among all patients, both breasts was likewise very small for the y coordinate 





























Right Breast 0.39  0.37 0.08 0.49  0.27 0.12 0.49   0.35 0.15 
Left Breast 0.26  0.37 0.08 0.39  0.23 0.08 0.34  0.28 0.07 
 41 
of the lowest visible point in the lateral view (1.15 pixels). The variability was 
moderately small (standard deviation ≈ 1.5 pixels) for most of the other fiducial points, 
the exception being the y coordinate of the lateral terminus of the inframammary fold 
(9.12 pixels). Over all, the clinical observers were extremely consistent over time in 
marking all of the fiducial points used in this study. 
 
 
Figure 3.4: Variability of fiducial point localization by expert over time (+: 1st trial, o: 2nd 
trial, ✼: 3rd trial). Expert observer (GPR) marked the fiducial points (left top: sternal 
notch, right top: left nipple, left bottom: the lowest visible point, right bottom: lateral 
terminus of inframammary fold). The sternal notch and left nipple are marked with white 
markers and the lowest visible point and the lateral terminus of the inframammary fold 





Figure 3.5: Variability of fiducial point localization by three experts at first trial (+: GPR, 
o: MJM, ✼: EKB). Three expert observers (GPR, MJM, EKB) marked the fiducial points 
(left top: sternal notch, right top: left nipple, left bottom: the lowest visible point, right 
bottom: lateral terminus of inframammary fold). The sternal notch and left nipple are 
marked with white markers and the lowest visible point and the lateral terminus of the 
inframammary fold are marked with black markers Four left oblique views of one patient 
were generated for example photographs. 
 
Figure 3.6 and Figure 3.7 illustrate examples of the variability between a clinical 
observer (GPR) and non-clinical observers. As is shown in these examples, overall the 
novice observers in this study were able to accurately mark the locations on the fiducial 
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points if the clinical observer’s marks are taken as the ground truth. Table 3.4 and Table 
3.5 report the maximum standard deviation across time for each fiducial point among all 
novice observers viewing all patients, both breasts. As was the case for the clinical 
observer group, the novice group shows the least variability of all the fiducial points for 
localizing the nipples in either view (standard deviations ≈ 1 pixels). In fact, the 
variability in localizing most of the fiducial points was similar for the clinical and novice 
observers, with two exceptions. In the oblique view, the novice observers showed 
considerably more variability for the x- and y- coordinates of the lateral terminus of the 
inframammary fold and the y coordinate of the sternal notch. These structures are among 
the more subtle fiducial points used in this study and these results indicate that additional 





Figure 3.6: Variability of fiducial point localization comparing an expert and novice 
groups for Measure (3.1).  Observers marked the fiducial points (left: sternal notch, 
middle: left nipple, right: lateral terminus of inframammary fold). Fiducial points marked 
by six observers are indicated with markers; +: expert observer and five novice observers: 
o, ✼, □, ◊,). The sternal notch and left nipple are marked in white and the lateral 
terminus of the inframammary fold is marked in black. Three left oblique views of one 




Figure 3.7: Variability of fiducial point localization comparing an expert and novice 
groups for Measure (3.2). Observers marked the fiducial points (left: left nipple, middle: 
lowest visible point, right: lateral terminus of inframammary fold). Fiducial points 
marked by six observers are indicated with markers; +: expert observer and five novice 
observers: o, ✼,□, ◊,). The left nipple is marked in white and the lowest visible point 
and the lateral terminus of the inframammary fold is marked in black. Three left oblique 
views of one patient were generated for example photographs. 
 
Table 3.4: Variability of marking fiducial points localization between clinical and novice 
groups for 10 patients (Figure 3.6). Eight observers (three clinical and five novices) 
marked the fiducial points using our new objective tools. Standard deviations of the 
fiducial points from Measure (3.1) (right and left oblique views) are tabulated. Minimum 
and maximum values of standard deviations from x- and y- coordinate are calculated 
across the three time points for each patient and each breast. 
(Clinical/ non-clinical) 









Sternal notch (s) 0.43 / 1.22 4.59 / 5.26 0.26 / 0.80 3.97 / 8.54 
Nipples (n) 0.25 / 0.18 1.64 / 1.79 0.25/ 0.41 0.71 / 2.74 
Lateral terminus of 
Inframammary fold (i) 0.25 / 2.01 6.38 / 12.50 0.71 / 1.32 5.30 / 11.38 
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Table 3.5: Variability of marking fiducial points localization between clinical and novice 
groups for 10 patients (Figure 3.7). Eight observers (three clinical and five novices) 
marked the fiducial points using our new objective tools. Standard deviations of every 
fiducial points from Measure (3.2) (right and left lateral views) are tabulated. Minimum 
and maximum values of standard deviations from x- and y- coordinate are calculated 
across the three time points for each patient and each breast. 
(Clinical/non-clinical) 









Nipples (n) 0.14 / 0.41 1.27 / 2.18 0.11 / 0.43 1.41 / 1.82 
Lateral terminus of 
Inframammary fold (i) 0.56 / 1.95 6.36 / 16.18 0.73 / 1.38 9.12 / 11.35 
Lowest visible Point 
(v) 0.25 / 0.47 3.28 / 2.87 1.01 / 0.28 2.31 / 1.46 
 
 
The time required for marking fiducial points by both the clinical and novice 
groups for 10 patients was studied (Table 3.6). The mean time required to locate each 
fiducial point in each trial was computed. The mean times required for marking all 
fiducial points for Measure (3.1) and Measure (3.2) were 46.44 seconds and 46.01 
seconds for the clinical and novice groups respectively. This result indicates that non-
surgeons can identify the fiducial points needed for our objective measures as quickly as 
surgeons can. It was also observed that the time needed to locate the fiducial points 
typically decreased with each trial for both the clinical and novice groups, presumably as 





Table3.6: Time required for marking fiducial points between clinical and novice groups 
for 10 patients. Eight observers (three clinical and five novices) marked the fiducial 
points using our new objective tools. Mean values of time for each fiducial point and 
each trial from Measure (3.1) and Measure (3.2) are computed. 
Clinical Group Novice Group  
1st / 2nd / 3rd / overall 1st / 2nd / 3rd / overall 
Nipples (n) 4.56 / 3.84 / 3.56 / 3.99 3.75 / 3.11 / 2.95 / 3.27 
Lateral terminus of 
Inframammary fold (i) 4.27 / 3.43 / 3.01 / 3.51 5.35 / 3.95 / 3.35 / 4.22 
Lowest visible Point (v) 3.73 / 3.45 / 3.35 / 3.51 4.20 / 3.85 / 3.15 / 3.74 
Sternal notch (s) 5.34 / 4.12 / 4.33 / 4.59 5.25 / 3.99 / 3.65 / 4.30 
Time required for all fiducial 
points in Measure (3.1) and 
Measure (3.2) per patient (four 
nipple points, four lateral 
terminus of Inframammary 
folds, two lowest visible points, 




3.3.3 Ptosis: objective measures 
Our objective measures for ptosis are expected to have values in the range from 0 
to 1, but the observer rating scale ranges from 0 to 3. I rescaled the values of our new 
measures to be more similar to the observer rating scales to simplify interpretation of our 
objective measures. The mean of the three clinical observers’ observer ratings at three 
time points were calculated over right and left breasts separately for 10 patient cases. 
Simple linear regression was used to relate the ptosis ratings obtained using the observer 
rating scale to our objective measures (Figure 3.8, Figure 3.9).  
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The simple linear regression model from clinical group was used to transform the 
objective measures from novice group’s distance ratios to a scale more similar to that of 
the observer rating scale to allow for easier interpretation of the objective measures. After 
rescaling the objective measures, I determined that the level of variability of the novice 
group in the objective ptosis measure resulted from variability in the fiducial point 
marking. Maximum variability from different observers for the same case at different 
time point was about 0.47 ptosis grade on Measure (3.1) (Table 3.7) and 0.42 ptosis grade 






Figure 3.8: Simple Linear Regression between ptosis ratings made by the clinical observer and Measure (3.1). A simple linear 
regression was used to relate average values computed for the objective measures to the observer ratings for 10 patient cases 
provided by three clinical observers (GPR, MJM, EKB). The regression data was used to transform the objective measure data 





Figure 3.9: Simple Linear Regression between ptosis ratings made by the clinical observer and Measure (3.2). A simple linear 
regression was used to relate average values computed for the objective measures to the observer ratings for 10 patient cases 
provided by three clinical observers (GPR, MJM, EKB). The regression data was used to transform the objective measure data 
of novices group for same patient cases to evaluate the impact of the variability from manual identification of the fiducial 
points. 
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Table 3.7: Maximum variability of ptosis grade after rescaling all five non-clinical 
observers’ objective Measure (3.1). Standard deviations of right and left breast are 
tabulated separately. 
 Right Breast Left Breast 
Patient #1 0.27 0.37 
Patient #2 0.11 0.31 
Patient #3 0.14 0.39 
Patient #4 0.10 0.33 
Patient #5 0.24 0.30 
Patient #6 0.18 0.12 
Patient #7 0.47 0.27 
Patient #8 0.09 0.35 
Patient #9 0.09 0.19 
Patient #10 0.06 0.26 
Table 3.8: Maximum variability of ptosis grade after rescaling all five non-clinical 
observers’ objective measure (3.2). Standard deviations of right and left breast are 
tabulated separately. 
 Right Breast Left Breast 
Patient #1 0.37 0.21 
Patient #2 0.17 0.24 
Patient #3 0.24 0.30 
Patient #4 0.24 0.21 
Patient #5 0.21 0.22 
Patient #6 0.42 0.18 
Patient #7 0.27 0.24 
Patient #8 0.07 0.27 
Patient #9 0.00 0.16 
Patient #10 0.02 0.18 
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Two additional simple linear regression analyses were performed for comparison, 
which I will refer to as models B and C. Regression model B was built on all 52 cases 
using the observer ratings from clinical group vs. the objective measurements based on 
the fiducial point markings of a single novice observer (MSK). The same modeling 
strategy was used for model C, with the difference that the 10 patient cases which were 
used for testing the rescaling of the novice group measurements were excluded. The 
results indicated that the maximum variability from different novice observers from 
model B were 0.50 ptosis grade on Measure (3.1) and 0.46 grade on Measure (3.2) and 
for model C were 0.48 ptosis grade on Measure (3.1) and 1.25 ptosis grade on Measure 
(3.2). Thus, the results of using model B, which used a larger number of cases but a 
smaller number of observers than the main model, were essentially equivalent to that of 
the main model. The results of using model C, in which the 10 cases being assessed were 
held out when the model was built, showed an increased variability as was expected. 
 
3.4 DISCUSSION AND CONCLUSION 
In this study, I designed quantitative, objective measurements of breast ptosis 
based on ratios of distances between fiducial points manually identified in lateral and 
oblique views of clinical photographs. Three clinical observers rated preoperative clinical 
photographs of 52 patients who underwent breast reconstruction for ptosis using a 
qualitative, observer rating scales at three time points (at least 2 weeks). Kappa statistics 
between time points indicated good to excellent intra-observer agreement (0.52-0.84), 
which encouraged our use of the average of the three observers’ ratings as a guide in 
assessing our new quantitative, objective measurements of breast ptosis. 
In our current implementation, fiducial points are manually identified. While still 
not ideal, it would be more practical to use manually identified fiducial points if the task 
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could be accurately performed by a non-clinical observer (e.g., a research assistant). In 
this study I found that novice observers could reliably locate the required fiducial points 
as compared to the identifications made by clinical observers. Moreover, both novices 
and clinical observers demonstrated low variability in repeated marking of fiducial points 
at different time points. Thus, it is practical to use our approach with novice observers. 
However, a more automated method would be better for large outcome studies or for 
developing intra-operative tools. It takes about 40 seconds per patient to mark the 12 
fiducial points required for the two ptosis measures presented here, though additional 
fiducial points would likely be needed to address other aesthetic properties (e.g., 
symmetry). 
Our quantitative, objective measurements of breast ptosis are based on ratios of 
distances between fiducial points. Typically, only the y coordinate, but not both are 
needed for any particular fiducial point. For measure (3.2), it was encouraging that for the 
lateral terminus of the inframmamary fold the coordinate used (y) was less variable than 
the one that wasn’t needed from the lateral view (x). A similar, but weaker trend was seen 
for the inframmamary fold in the oblique view used for measure (3.1). In future studies, 
the effect of the patient's body-mass index should be examined since the small sample 
used in this study suggests that some landmarks such as the sternal notch are more 
difficult to locate on heavier patients. 
A simple linear regression model was developed to relate the observer ratings and 
objective measurements for 10 patient cases by the clinical observers. The regression 
model was used to rescale the objective measurements of the novice group to allow for 
easier interpretation of the variability in the measures due to variability in fiducial point 
identification. The objective measures from novice group showed that the maximum 
variability from different novice observers for the same cases at different time point was 
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about 0.47 ptosis grade on Measure (3.1) (Table 3.7) and 0.42 ptosis grade on Measure 
(3.2) (Table 3.8). 
Over all there was good agreement between the novice and clinical observers, but 
some differences were seen. While both clinical and novice observers showed the same 
trend of some fiducial points being easier to reliably locate than others (e.g., lateral 
terminus of inframammary fold vs. nipples), the differences between the easier and more 
difficult points were larger for the novice observers. These observations suggest that 
additional training may be desirable for novice observers, particularly for more subtle 
structures, such as the sternal notch. 
One potential limitation of objective measurements of breast ptosis based on 
ratios of distances between fiducial points is that they could be difficult to interpret. We 
addressed this problem by building a linear regression model that relates the objective 
measurements to observer ratings. The linear regression model was then used to rescale 
each ratio to provide a final quantitative, objective measure that can be interpreted in the 
same manner as the more familiar observer rating scale for ptosis. The level of variability 
of the objective measures of novice observers after rescaling was found to be equivalent 
to less than half of a point on the observer ptosis scale. This result indicates our new 




Chapter 4: ASSESSMENT OF ARTIFICIAL SURGICAL SCARS: 
COMPARISON OF PHOTOGRAPHY AND COLORIMETRY  
Contribution and publication: A preliminary version of the study in this chapter will be 
presented at the American Medical Informatics Association Annual Symposium and a 
manuscript is being prepared for submission to a journal. 
1. M. S. Kim, W. N. Rodney, G. P. Reece, T. Cooper, and M. K. Markey, "Toward 
Quantifying the Aesthetic Outcomes of Breast Cancer Treatment: Comparison of Clinical 
Photography and Colorimetry," in American Medical Informatics Association Annual 
Symposium Chicago, Illinois, 2007. 
4.1 INTRODUCTION 
4.1.1 Breast surgical assessment 
All types of breast surgery, including breast reconstruction, leaves scars that can 
be disfiguring, aesthetically unpleasant, and can negatively affect a patient’s quality of 
life [151-153]. Scars can cause itching, tendernesits, pain, sleep disturbances, anxiety, 
depression, and disruption of daily activities. Other psychosocial complications include 
development of post-traumatic stress reactions, loss of self-esteem, and stigmatization 
[151, 152].  
Scar tissue is physically different from normal tissue and can have abnormal 
color, rougher texture, and increased thickness and firmness [154]. The five main 
categories of scarring are defined by the growth and characteristics of the scar tissue 
[151]. Widespread scars appear when the fine lines of surgical scars gradually become 
stretched and widened, usually within three weeks of surgery. Atrophic scars are 
generally small and often round with an indented center below the surrounding skin. Scar 
contractures are scars that cross-joints or skin creases at right angles and are prone to 
develop shortening or contracture. Hypertrophic scars are raised scars that remain within 
the boundaries of the original lesion and typically occur after burn injury on the trunk and 
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extremities. Keloid scars are raised scars that spread beyond the margins of the original 
wound and invade the surrounding normal skin in a way that is site specific. 
Assessment of aesthetic outcomes, including scarring, is important to protect 
patients’ health and well-being [59], but there is no accepted method for assessing the 
appearance of surgical scars. Most assessments of surgical scars by clinical observers 
[94], patients [88], or combinations of both [91] have only been studied as subscales for 
aesthetic outcome measures (Table 4.1). Visibility, the extent the surgical scar detracts 
from the aesthetic outcome, is the accepted method to assess the scarring in breast 
reconstructive surgery.  
Commonly used visual assessments are a 3-point scale (Good, fair, poor) [94, 
155], a 4-point scale (Excellent, good, fair, poor) [95] or a 5-point scale (Excellent, good, 
satisfactory, poor, unacceptable) on breast mound scars. These global assessments have 
been based on postoperative photographs [153] or direct views of patients and show 
unacceptable inter-rater reliability [94] and inability to consider all of the relevant 
aesthetic features of scars. 
Quantitative assessment methods study the mechanical properties, size, and color 
of the scar area (Table 4.2). However, while mechanical properties of scars influence the 
comfort of a patient, they do not impact the visibility, and thus the aesthetics, of scars. 
The visibility of a scar is significantly influenced by surface area, vascularity, and 
pigmentation [156].  
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Table 4.1: Summary findings of Observer Scar Assessments 
Reference Scale Test Population  Findings 
Veiga 
[155] 
3-point scale with subscales 
(breast scars) 
20 patients of unilateral 
mastectomy  
The inter-rater and intra-rater agreement was poor to 




4-point, subscales (breast 
scars) 
50 photographs of BRC 
patients 
Suggested explicit criteria and to separate various 
components of the aesthetic result to improve the 
reliability of the assessment (
! 
"appa = 0.31) 
Andrade 
[88] 
5-point, subscales (Appearance 
of surgical scars, Aesthetic 
result of breast reconstruction) 
214 questionnaires 
returned by patients of 
BRC 
Significant association was found between overall 




7-point, subscales (scar on the 
breast) 
Photographs of 53 
patients of TRAM-
pedicled flap 
reconstruction   
A strong correlation between the patients’ and the 
panel’s evaluations of the aesthetic outcome was 
seen; generally, the panel’s evaluation of the 
aesthetic result of the breast correlated with the 





4-point scale with subscales 
(scar, size, shape, color, 
firmness) 
76 Photograph of BCT 
patients 
Reported higher intra-rater agreement between the 
nurse and the oncologist (
! 
"appa = 0.64 ) but lower 
inter-rater agreements between ratings by patients 
and clinical observers (
! 




5-point scale, subscales (breast 
scar)  
34 photograph of 
reduction mammaplasty 
Scarring was the most frequent cause of 
dissatisfaction for both surgeons and patients.  
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Table 4.2: Summary findings of Quantitative Scar Assessments and Measures 
Reference Test Population Findings 
Truong 
[157] 
59 breast cancer 
patients 
VSS, patient self-rating scale, and Short-Form McGill Pain Questionnaire had 
acceptable internal consistency (Cronbach’s 
! 
"  = 0.79, 0.64, 0.72). Patient satisfaction 
was not significantly associated with VSS scores. 
Kar 
[156] 
100 linear surgical 
scars 
Internal consistency of observer and patient scales was good (Cronbach’s 
! 
"  = 0.86 
and 0.90, respectively) and reliability of the observer scale was good for the total score 
(Pearson r = 0.96, p < 0.001).  
Sullivan 
[158] 




49 scar areas in 20 
patients 
Reliable measurements with the DermaSpectrometer and Minolta Chroma-Meter 
(Pearson r = 0.72). At least three observers necessary with for reliable pigmentation 
measurement (Pearson r > or = 0.77).  Agreement for observers for pigmentation was 
unacceptable (kappa = 0.349). 
Setaro 
[160] 
348 photographs of 
Caucasian  
Clinically useful digital measurement of absent, slight, and moderate erythema using 




Photographs of 9 
subjects of White, 
Asian, or African-
American  
Feasible to use digital photography for objective evaluation of UV erythema and 
pigment changes due to UV exposure in different racial/ethnic groups even with light 
to heavy UV exposure schedules (Pearson r = 0.66, 0.96, 0.93).   
Zuijlen 
[162] 
20 normal volunteers Planimetry by photography is more reliable than planimetry by tracings for areas that 
are not extremely curved. 
Hurtut 
[163] 
undefined number of  
scoliosis patient images 
 
Encouraging results with an average deviation using automatic contours compared to 
manual contours of 0.67± 0.24
! 
mmwith a camera resolution of 1.8 
! 
mm . This is less 




Since the size and color of scars have the largest influences on the overall 
visibility, quantitative ways of obtaining these data have been of great interest [156, 159, 
164, 165]. Vascularity and pigmentation can be separately evaluated by observing the 
color of the scar before and after it is blanched using a tool such as a piece of clear plastic 
[156, 165]. However, for purposes of quantifying the visibility of scars, it is not necessary 
to distinguish between coloration due to vascularity vs. pigmentation [166]. Currently, 
observers assess the outcome of scars either by manual inspection, clinical instruments or 
combinations. This can be time consuming, demanding of the patient, and expensive with 
equipment costs. An effective, practical means of quantitatively assessing scar color is 
needed and digital images can be used for this assessment. 
Towards this aim, this chapter will discuss the potential color assessment method 
on surgical scars using digital photograph and the following chapter will discuss area 
measurement methods on real scars.  
 
4.1.2 Color assessment 
To standardize the quantification of color, CIE (International Commission on 
Illumination) recommended tri-stimulus color values XYZ, which are read using 
spectrometric reflectance data from an object and three primary stimuli strictly defined by 
the commission. CIE L*a*b* (CIELAB) is the most complete color model used 
conventionally to describe all the colors visible to the human eye. The three parameters in 
the model represent the lightness of the color (L*, L* = 0 indicates black and L* = 100 
indicates white), its position between magenta and green (a*, a* = -60 indicates green and 
a* = 60 indicates magenta), and its position between yellow and blue (b*, b* = -60 
indicates blue and b* = 60 indicates yellow) [167].  
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While for purposes of assessing scar visibility it is not necessary to separate the 
color contributions from the underlying physiological factors of vascularity and 
pigmentation, for completeness I briefly review how the color parameters are known to 
relate to the skin physiology. Studies have shown that L* and melanin index correlate 
almost linearly if the Hb (oxyhemoglobin) amount is constant. The a* and erythema 
index values correlate almost linearly with the amount of Hb in the superficial plexus. 
These findings suggest that L*, b*, or combinations of them are reasonable 
parameters for evaluation of the degree of pigmentation if the cutaneous blood volume is 
considered to be similar at all sites. The a* index is a good parameter for evaluating the 
degree of erythema or cutaneous blood volume. The difference values between the test 
and control sites are the best parameters for evaluating erythema and pigmentation [168]. 
These findings suggest that a combination of L* and b* can be used for measuring 
pigmentation and a* can be used for evaluating the redness of surgical scars. Although all 
of the L*a*b* parameters are important indicators of vascular changes or pigmentation, 
the a* parameter is the most relevant and sensitive one for erythemous or vasodiatatory 
change [167].  
The drawback to the use of colorimeters is that they require direct patient 
interaction and can cost thousands of dollars. By comparison, digital photography is 
already in widespread use to document clinical outcomes. Moreover, digital photographs 
can be evaluated after the fact and so required less patient interaction. Thus, assessment 





Figure 4.1: The L*a*b* color space, 
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Towards this aim, it is encouraging that digital photography has been 
demonstrated to be a viable alternative to color measurements by a colorimeter for 
objective evaluation of UV erythema. Coelho et al. used the change in the a* parameter 
to quantify erythema, and ΔL was used to evaluate the level of pigmentation that 
develops during tanning for three subjects in each of three ethnic/racial groups: Asian, 
Black or African American, and White [169]. They reported their computer assisted 
digital image evaluation (CADIE) system, which uses a commercial digital SLR camera, 
a Nikon D1 (Nikon, Tokyo, Japan), and image processing software, Adobe Photoshop 6.0 
(Adobe Systems, San Jose, CA), produced results comparable to those obtained with a 
spectroscopy system, the Minolta CM 2002 (Minolta, Ramsey, New Jersey). They found 
good agreement between the Δa* (Pearson r = 0.77-0.97) and ΔL* (Pearson r = 0.66-
0.96) generated by the two methods. 
Careful experimental control and standardization is needed in order to collect 
precise color information. Past studies found that an artificial skin model could be 
successfully created to control the experimental environment and to demonstrate the 
diversity of color of skin regions [170, 171]. In particular, a multilayered skin model was 
developed to measure the amount of melanin and hemoglobin with a microscope 
interfaced with a computer and the values were compared with those of real skin regions. 
Similarly, in this study, artificial scars created by a makeup artist were employed in order 
to achieve maximal control of the experimental set up, i.e., there was no hemoglobin in 
the makeup used to create the artificial scar. 
In this chapter, I compared color measurements obtained by clinical digital 
photography to those from a standard colorimeter. Experimental conditions were 
controlled by performing measurements on artificial scars created by a makeup artist 
(TC). The colorimeter measurements of the artificial scars were compared to those 
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reported in the literature for real scars in order to confirm the validity of this approach. 
Agreement in photographic and colorimeter measurements was statistically analyzed 
using the hypothesis test for equivalence [172], the ICC coefficient [173], and the Bland-
Altman method [174, 175].  
  
4.2 MATERIALS AND METHODS 
4.2.1 Artificial scar creation on models 
Two female models in their early twenties representing two major race groups 
(Model A: White and not Latino or Hispanic, Model B: Black or African American and 
not Latino or Hispanic) were hired for the study. Their demographic and clinical 
background information is summarized in Table 4.3. Neither of the two models has a 
history of pregnancy or lactation, but Model B has a history of breast surgery on her left 
side approximately 7 years ago. 
A makeup artist (TC) created 6 types of scars while taking into consideration the 
reality of the scar appearance from a distance, excessive shine, and the utilization of latex 
or collodion makeup (Table 4.4). An experienced plastic surgeon (GPR) guided the 
creation of artificial scars that emulate the appearance of scars that would result after 
breast reconstruction with a latissmus dorsi (LD) flap or a transverse rectus abdominis 
myocutaneous (TRAM) flap. In LD reconstruction, the flap is composed of an elliptical 
patch of skin that lies over the latissimus dorsi muscle. Typically, the flap is used to 
replace the breast skin removed during the mastectomy and the breast volume is replaced 
with a breast implant [65]. The TRAM is the most popular form of tissue-based breast 
reconstruction, wherein a flap from the abdomen, either with blood vessels intact or 
completely severed from the body, is transferred to the chest either via a subcutaneous 
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tunnel or using microsurgical technique to replace the breast skin and volume [70, 71, 




Table 4.3: Clinical and demographic background information of Model A and Model B. 
None of two models had history of pregnancy or lactation, but Model B has a history of 
breast surgery on left side about 7 yeas ago, which might affect the aesthetic assessment 
of the breast. 
 Model A Model B 
Age (in years) 21 22 
Weight (in kg) 57 64 
Height (in cm) 170 173 
Bra size  36 36 
Cup size (A, B, C, D) B C 
Ethnicity Not Hispanic or Latino Not Hispanic or Latino 
Race White Black or African American 
Tanning booth exposure Have had blister burns. Not 
more than 4 hours of sun 
per week 
 
Never tan in a booth 
Sometimes sunbath outside 
no more than an hour, with 
sun block though. SPF 50. 
Sunscreen use No routine use of sunscreen Always. And waterproof. 
 
Pregnancy and lactation 
history 
None None 
Estrogen use Oral contraceptive Oral contraceptive  
Previous breast surgery None Had a benign tumor in left 
breast removed at 15 
Fitzpatrick Skin Type (FST) 
[179]  
II. Burn and minimal tan, 
Pale white 
VI, Tan, no burn, Dark 
brown 
Notes on FST Mainly burns, but little tan Have never had a sun burn 
Ptosis grade [5, 180]  0: Nipple and most of gland 
are above IMF 
2: Nipple is below IMF, but 
above lower contour of the 
breast 
Pseudoptosis No No 
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Table 4.4: Artificial scars created on Models A and B. The scars created for Model A 
resemble normal, hypertrophic scars that are raised scars that remain within the 
boundaries of the original lesion typically seen 3 to 6 months (Figure 4.2, Figure 4.3, 
Figure 4.4). The scars created for Model B resemble normal, hypertrophic scars (Figure 
4.5, Figure 4.6) and keloid scar  (Figure 4.7), typically seen 6 months to 1 year after 
surgery. All scars were created on left breast around the nipple-areola complex (NAC) 
with incision running into the low superior lateral area.  
 Scar A1 Scar A2 Scar A3 Scar B1 Scar B2 Scar B3 
Location       
Side Left Left Left Left Left Left 

















0 None 1 0 0 4 
Width 
(in mm) 
3 None 3 2 6 4 
Length  
(in mm) 
5 None 5 6 9 9 
 
 
The scars created for Model A resemble normal scars (Figure 4.2, Figure 4.3), and 
hypertrophic scars (Figure 4.4), raised scars that remain within the boundaries of the 
original lesion, as typically seen 3 to 6 months after surgery. Scar A1 was created on left 
breast around the nipple-areola complex (NAC) with the incision running into the low 
superior lateral area. Scar A2 was started from Scar A1 and the scar was expanded 
around the NAC into the medial region of the left breast. Liquid latex was added on Scar 






Figure 4.2: 2D image of Scar A1 on Model A. The scars created for Model A resemble 
normal scars that are typically seen 3 to 6 months after breast reconstruction surgery with 
either LD or TRAM flap. No donor site scar was created in this study. Scar A1 was 
created on left breast around the nipple-areola complex (NAC) with incision running into 
the low superior lateral area. Scars were created by adding base color and top color 




Figure 4.3: 2D image of scar A2 on Model A. The scars created for Model A resemble 
normal scars that are typically seen 3 to 6 months after breast reconstruction surgery with 
either LD or TRAM flap. No donor site scar was created in this study. The scar was 
expanded around the nipple area into the medial region of the breast. Scars were created 
by adding base color and top color makeup on the base of either latex or rigid collodion or 




Figure 4.4: 2D image of scar A3 on Model A. The scars created for Model A resemble 
hypertrophic scars that are typically seen 3 to 6 months after breast reconstruction 
surgery with either LD or TRAM flap. No donor site scar was created in this study. Scars 
were created by adding base color and top color makeup on the base of either latex or 
rigid collodion or combination of these. Liquid latex was added to make nipple more 
asymmetric on Scar A3. 
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The scars created for Model B resemble normal scars (Figure 4.5), hypertrophic 
scars (Figure 4.6), and a keloid scar (Figure 4.7), a scar that has spread beyond the 
margins of the original wound and invades the surrounding normal skin [59]. The scars 
on Model B resemble those typically seen 6 months to 1 year after surgery. Scar B1 was 
created on left breast around the nipple-areola complex (NAC) with incision running into 
the low superior lateral area. Scar B2 was started from Scar B1 and crescent shaped 
region to lateral side of areola was added. Scar B3 was built off from Scar B2 and added 




Figure 4.5: 2D image of scar B1 on Model B. The scars created for Model B resemble 
normal scars that are typically seen 6 months to 1 year after breast reconstruction surgery 
with either LD or TRAM flap. No donor site scar was created in this study. Scar B1 was 
created on left breast around the nipple-areola complex (NAC) with incision running into 
the low superior lateral area. Scars were created by adding base color and top color 
makeup on the base of either latex or rigid collodion or combination of these.  
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Figure 4.6: 2D image of scar B2 on Model B. The scars created for Model B resemble 
hypertrophic scars that are typically seen 6 months to 1 year after breast reconstruction 
surgery with either LD or TRAM flap. No donor site scar was created in this study. Scars 
were created by adding base color and top color makeup on the base of either latex or rigid 
collodion or combination of these. Scar B2 was started from Scar B1 and crescent shaped 




Figure 4.7: 2D image of scar B3 on Model B. The scars created for Model B resemble 
keloid scars that are typically seen 6 months to 1 year after breast reconstruction surgery 
with either LD or TRAM flap. No donor site scar was created in this study. Scars were 
created by adding base color and top color makeup on the base of either latex or rigid 
collodion or combination of these. Scar B3 was built off from Scar B2 and added rigid 
collodion to create a keloid appearance 
 
The basic scar shape was initially created using liquid latex, rigid collodion, or a 
combination of these products on top of alcohol cleansed skin in order to get the desired 
effect. The simulated scars were then covered with a natural skin-toned base foundation 
to help blend the edges of the created scars with the bare skin. Top detailing color 
makeup in various tones was next meticulously placed over the simulated scars to give 
them a more organic appearance. Neutral set powder was pressed over the simulated 
scars to finalize the makeup and to reduce shine. For Model A, the following top 
detailing colors were used to create all three artificial scars (Mehron Inc., Chestnut Ridge, 
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New York): Mehron ProColoRing Bruise "Bloody Rose", Mehron ProColoRing Bruise 
"Midnight Sky", Mehron ProColoRing Bruise "Burnt Maroon". For Model B, Mehron 
ProColoRing Bruise "Midnight Sky" was used to create scar B1 (Figure 4.5) and scar B2 
(Figure 4.6) whereas Mehron ProColoRing Bruise "Midnight Sky" and Mehron 
ProColoRing Bruise "Burnt Maroon" was used to create scar B3 (Figure 4.7) 
 
4.2.2 Color measurements using a colorimeter 
One of the widely used opto-electric tri-stimulus instruments commercially 
available for measuring skin colors in dermatology area is the Chroma-Meter (Konica 
Minolta, Osaka, Japan) [181-183]. Previous studies of the Chroma-Meter CR300 on 
normal skin have reported excellent intra-observer agreement (ICC ≥ 0.98) and good to 
excellent inter-observer agreement (ICC ≥ 0.85) for all of the three parameters (L*a*b*) 
[182].  
A Chroma-Meter CR300 was used to record color information of specific regions 
of interest defined by a plastic surgeon (GPR). Before measurements were taken, the 
instrument was calibrated to a standard white plate provided by the manufacture. One 
measurement consisted of three consecutive flashes of illumination to obtain a mean 
value. Before any scar was created, color was measured between the breasts, on each 
breast mound, on the tan line (if applicable), in each nipple region, and of any natural 
scars. Only the skin color measured between the breasts were grouped and the mean 
value was taken as the control value for normal skin to which the color values of artificial 
scars and natural scars were compared. 
For each artificial scar, color was measured on the scar region and multiple 
measurements were performed if the scar varied substantially in width. For accuracy and 
consistency of measurement, calibration was performed before a scar was created and 
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each time a new scar was created. A total of seven calibrations were used for the 
measurements. Past studies have shown that there are significant differences between the 
color parameters of hypertrophic scar regions (aged 6-12 months) due to burns, scalds, 
trauma and surgical incisions and normal skin regions, including upper arm, forearm, 
hand, chest, abdomen, back, and thigh [184]. The L* and b* values of normal skin 
collected using a spectro-colorimeter, Lab Scan XE (Hunter Associates Laboratory, Inc. 
Reston, VA), were significantly higher than those of hypertrophic scars, while 
measurements of a* of hypertrophic scars were significantly higher than those of normal 
skin. The authors did not report data on variability across racial groups in these trends of 
normal vs. scar measurements. To verify that our artificial scars also exhibit these 
properties, I analyzed the differences between normal skin regions and hypertrophic scars 
in CIE L*a*b*. 
 
4.2.3 Color measurements using a camera 
30 photographs, including before and after the artificial scars were applied, in sets 
of five standard views (AP, left oblique, left lateral, right oblique, right lateral), were 
taken. A Nikon 8400 was employed for all scar photographs because it is the model most 
commonly used for record keeping at The University of Texas M. D. Anderson Cancer 
Center. The main light source was overhead fluorescent lighting, and the camera was set 
to white balance, fluorescent lighting with ISO of 400. The aperture priority mode was 
set to the smallest value with spot metering for exposure level selection. Image quality 
was set to highest level possible to catch the details of the scars. The model stood in front 
of a sky blue background wall. Distance from subject to lens barrel was standardized to 
150 cm. 
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For this study, scar regions of interest (ROIs) were delineated using the polygon 
selection tool of ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of Health, 
Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2007) by looking at the 
images at 400% zoom ratio on the computer screen with consistent resolution and size 
(1490×900). The RGB values were collected from each image for both the scar, and 
normal skin regions (between breasts). The reference values of “C” white used for the 
computations were provided by the Chroma-Meter CR300 instruction manual [185]. The 
CIE L*a*b* data of scar regions from photography were compared with those of 
colorimeter. 
 
4.2.4 Statistical analysis 
The agreement between color measurements obtained by colorimeter and digital 
photography was analyzed separately for each model. Three different statistical methods 
were used because each method has its technical limitations [186]. The methods used 
were: the Bland-Altman methods [174, 175], a hypothesis test for equivalence [172], and 
the ICC [173]. The Bland-Altman method provides a qualitative assessment while the 
hypothesis test for equivalence and ICC methods provide quantitative measures of 
agreement between measurements.  
 
4.2.4.1 Bland-Altman method 
Bland-Altman method is used for qualitatively measuring the degree of 
agreement, where the differences between photographic and colorimeter measurements 
are plotted against the average value of these measurements. If 95% of the differences are 
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within ±1.96 standard deviations of the mean of the differences, than the two methods are 
considered to be in good agreement. 
 
4.2.4.2 Hypothesis test for equivalence 
In testing for equivalence between two measurements, the null hypothesis is that 
the measurements by photography are not equivalent to those by colorimeter and the 
alternative hypothesis is that they are equivalent. This hypothesis is specifically intended 
for assessing equivalence and is distinct from that of the familiar paired t-test wherein a 
null hypothesis of equal value and an alternative hypothesis of unequal value are 









x  and 
! 
s denote the mean and standard deviation, respectively, of the 
differences between the photographic and colorimeter measurements. The value of 
! 
"  is 
computed as a factor multiplied by the mean of the measurements by colorimeter. In this 
study, the factor was 0.20, 0.25, or 0.30. The variable 
! 
"  accounts for the expected 
variability in the measurements made by two methods. A smaller value of 
! 
"  implies 
stricter criteria for demonstrating that the measurements of the two methods are 
equivalent, in other words, photography can be used in place of colorimeter. 
 
4.2.4.3 Intraclass correlation coefficient 
To report the agreement between two measurements, a single-score two way 
random model was used since the set of images is a random subset of images from the 
 75 
class of representative cases of post-operative images and the camera and colorimeter are 























where n denotes the number of scar measurements by photography and 
colorimeter and, k denotes the number of measurement methods, 
! 
MS




E  is the residual mean square error, and 
! 
MS
C  is the mean square error 
between photographic and colorimeter measurements, respectively. The guideline for the 
interpretation of ICC used is that an ICC value of less than 0.40 indicates poor 
reproducibility, ICC values in the range 0.40 to 0.75 indicate fair to good reproducibility, 
and an ICC value of greater than 0.75 shows excellent reproducibility [187].  
 
4.3 RESULTS 
4.3.1 Comparison of artificial scars 
Colorimeter measurements (CIE L*a*b*) of the artificial scars and normal skin 
were evaluated for characteristic differences (Table 4.5, Table 4.6) anticipated based on 
prior knowledge. Recall that the L*a*b* parameters indicate lightness, redness, and 
yellowness, respectively. The normal skin regions of model B had significantly higher a* 
and b* values than the normal skin regions of model A, while model A had a 
significantly higher L* value. This result is consistent with expectations since model B 
has a darker skin tone than Model A [188]. 
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A similar pattern was seen when color measurements of the artificial scar regions 
were compared between the two models. Recall that the scars created for Model A 
resemble normal scars (Figure 4.2, Figure 4.3) and hypertrophic scars typically seen 3 to 
6 months after surgery (Figure 4.4). The scars created for Model B resemble normal scars 
(Figure 4.5), hypertrophic scars (Figure 4.6) and keloid scar (Figure 4.7), typically seen 6 
months to 1 year after surgery. The artificial scars of model B had substantially higher a* 
and b* values than the artificial scars of model A, while model A had a substantially 
higher L* value. This result is consistent with our expectations from clinical experience 
that scar colors vary across racial groups, but I am unaware of any systematic studies that 
have evaluated this trend. There were no notable differences between the L* and a* 
values of Model B’s natural scar and those of the artificial scars created upon her skin. 
However, the artificial scars had lower b* values (less yellow) than her natural scar. I am 
unaware of any prior studies reporting how colorimeter measurements of scars change as 
scars mature. Thus, it is difficult to compare the measurements of the artificial scars, 
which were designed to emulate scars 6-12 months following surgery, to the subject’s 
real scar, which was several years old. 
Table 4.5 shows the colorimeter measurements of artificial scars created on 
Model A, and their comparison with those of her normal skin. Likewise, Table 4.6 shows 
the colorimeter measurements of artificial scars and normal skin of Model B. Artificial 
scars on model A had slightly lower L* values and substantially higher a* values than her 
normal skin. Similarly, artificial scars on model B also had slightly lower L* values and 
slightly higher a* values than her normal skin. In other words, as expected, the artificial 
scar regions look darker and redder than normal skin regions, as is the case for real scars. 
A previous study reported similar trends in the L* and a* measurements of real 
hypertrophic scars (6-12 months after skin injury) as compared with normal skin regions 
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[184]. In contrast, they reported that scars are less yellow (lower b* value) than normal 
skin [184]. However, there was no notable difference in the b* values of Model A’s 
artificial scars and her normal skin or between the artificial scars and normal skin of 
Model B. Note that the authors [184] did not report data on variability across racial 
groups in these trends of normal vs. scar measurements. 
The L*a*b* values of the artificial keloid scar (scar B3) were significantly lower 
than those of the artificial hypertrophic scars (scars B2). In other words, the artificial 
keloid scar was darker, less red, and less yellow than the artificial hypertrophic scars. 
This result is consistent with our expectations since hypertrophic scars should be lighter 
due to less melanin, redder due to the increase in vascularity, and less yellow as keloids 
are usually dark brown to black from clinical experience. However, I am unaware of any 
studies in which colorimeter measurements of keloid and hypertrophic scars were 
compared.
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Table 4.5: Comparison between normal skin region and hypertrophic scar region of Model A in L*a*b* color space. L*a*b* 
parameters indicate lightness, redness, and yellowness, respectively. Group A scars showed slightly lower L* value and 
significantly higher a* value than normal skin. This result shows that artificial scar regions look darker and redder than normal 
skin regions, while there was no significant difference in b* value, which indicates no prominent yellowness between artificial 
scars and normal skin. 
 Scar A1 Scar A2 Scar A3 Art. Scar Mean Normal skin Mean 
L*  74.75 53.72 70.33 66.27 67.00 
a* 5.59 9.70 8.92 8.07 3.28 
b* 6.00 17.78 13.72 12.50 11.12 
 
Table 4.6: Comparison between normal skin region and hypertrophic scar region of Model A in L*a*b* color space. L*a*b* 
parameters indicate lightness, redness, and yellowness, respectively. There were no notable difference observed in L* and a* 
values between group B artificial scars and natural scar, except significantly and consistently lower b* in group B. There were 
no notable differences in all three L*a*b* values between natural scar and normal skin, because natural scar was 7 years aged 
according to Model B’s history, and it was stabilized enough and didn’t stand out against surrounding normal skin.  
 Scar B1 Scar B2 Scar B3 
(Keloid) 




L* 41.02 64.07 34.43 46.51 46.74 49.28 
a* 10.02 14.36 6.37 10.25 11.85 9.74 
b* 
10.55 10.84 6.63 9.34 17.89 19.68 
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4.3.2 Inter-rater agreement 
The agreement between photographic and colorimeter measurements was 
analyzed using the Bland-Altman method, a hypothesis test for equivalence, and ICC. 
Agreement was assessed separately for each model and was based on measurements of 
three artificial scars per model.  
The degree of agreement between the measurements was also analyzed using the 
Bland-Altman method. Good agreement between the photographic and colorimeter 
measurements was obtained for all three parameters for both Models A and B as 
indicated by the fact that 95% of the differences were within the limit of agreement 
defined by Bland-Altman (Figure 4.8). 
Using a hypothesis test for equivalence, agreement between the photographic and 
colorimeter measurements was demonstrated for both models at the 20% level for the a* 
(p = 0.03, p = 0.03) and b* (p = 0.01, p = 0.01) parameters (Table 4.7). Equivalence was 
also achieved at the 20% level for L* in Model B (p = 0.04), but was not achieved even at 
the 30% level for the L* value for Model A (p = 0.08). 
Similarly, the degree of agreement between the measurements was assessed using 
the ICC (Table 4.8). ICC results were consistent with the hypothesis test for equivalence 
and Bland-Altman in that that there was “excellent” agreement between photographic and 
colorimeter measurements for the L* value of Model A (ICC = 0.99) and “fair to good 
agreement” for the L* value (ICC = 0.56) for Model B. In contrast to the other statistical 
assessments, ICC indicated unacceptable agreement in the a* and b* values (0.05–0.34) 
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(a) L* value-Model A 
 
(d) L* value-Model B 
 
(b) a* value-Model A 
 
(e) a* value-Model B 
 
(c) b* value-Model A 
 
(f) b* value-Model B 
Figure 4.8: Bland-Altman analysis for the agreement of scar groups A (a, b, c) 
and B (d, e, f) between the measurements of three artificial scars (N = 3) for each 
of the three parameters that were measured by colorimeter and digital camera. 
The parameters measured were: (a) L value, (b) a* value, and (c) b* value. The 
results show that good agreement was obtained for all three parameters measured 
as indicated by the fact that 95% of the differences were within the limit of 
agreement defined by Bland-Altman. 
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Table 4.7: Results of the hypothesis test for equivalence of scar group B for three CIE L*a*b* parameter values of six artificial 
scars (N = 3) as measured by a camera and a colorimeter. Equivalence was achieved at 20% variability in all three color 
parameters except in group A, where equivalence was not achieved even at 30% in L* value. The null hypothesis was that the 
photographic and colorimeter color measurements are not equivalent. δ = factor*mean of colorimeter measurement. A p-value 
less than 0.05 indicates that the color measurements obtained by photography and colorimeter are equivalent. 
Factor L* 
Group A   Group B 
a* 
Group A   Group B 
b* 
Group A   Group B 
0.30 p = 0.08 p = 0.02 p = 0.03 p = 0.03 p = 0.01 p = 0.01 
0.25 p = 0.21 p = 0.02 p = 0.03 p = 0.03 p = 0.01 p = 0.01 
0.20 p = 0.22 p = 0.04 p = 0.03 p = 0.03 p = 0.01 p = 0.01 
 
Table 4.8: Intra-class correlation (ICC) coefficient of group A and B for three CIE L*a*b* parameter values of six artificial 
scars as measured by a colorimeter and a camera. Mixed agreement was shown that group A (N = 3) showed “excellent” 
agreement for the L* value (ICC = 0.99), and “fair to good agreement” in group B for the L* value (ICC = 0.56), while Both 
group A and B showed unacceptable agreement in a* and b* values (0.05–0.34). The guideline for the interpretation of ICC 
used is that an ICC value of less than 0.40 indicates poor reproducibility, ICC values in the range 0.40 to 0.75 indicate fair to 
good reproducibility, and an ICC value of greater than 0.75 shows excellent reproducibility. 
 L* value a* value b* value 
Group A (N = 3) ICC = 0.56 ICC = 0.34 ICC = 0.16 
Group B (N = 3) ICC = 0.99 ICC = 0.29 ICC = 0.05 
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4.4 DISCUSSION AND CONCLUSION 
While colorimeters have been widely accepted as reliable tools for the assessment 
of skin color in Dermatology, they have not been routinely utilized in the Plastic and 
Reconstructive Surgery. However, digital photography is commonly used to document 
surgical outcomes. Thus, it would valuable if digital photography could also be used to 
quantitatively evaluate skin color. In order to assess the validity of color measurements 
obtained by clinical photography, I compared the measurements of a digital camera and a 
colorimeter. In order to conduct controlled experiments, artificial scars created by a 
makeup artist (TC) on professional models under the guidance of an experienced plastic 
surgeon (GPR) were used in this study. Comparisons between normal skin regions and 
artificial hypertrophic scars in CIE L*a*b* were consistent with expectations based on 
prior experience and previous studies [184]. Using multiple statistical methods, I 
demonstrated that color measurements obtained by digital photography were equivalent 
to those obtained using a colorimeter. Differences across the statistical methods may be 
due to the limited sample size (N=3 for each scar groups) I employed in this study. This 
study suggests that clinical photography can be employed for reliable, effective 
measurement methods of skin color for the analysis of surgical outcomes, but future, 
larger analyses employing real scars are needed.  
While our results support the use of clinical photography for quantitative 
measurements of skin properties such as scarring, it is important to note that 
standardization of photographic conditions is critical. Substantial variability may be 
observed if the photographic conditions are not controlled. Important parameters to 
standardize include: lighting intensity, distance and direction from the light to the subject, 
camera lighting settings, background color, and the subject’s pose relative to the camera. 
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While studio lighting is typically recommended for standardization of photography [121], 
in practice, this may not be feasible since it requires special equipment and training and 
that not be available to all clinicians. Fortunately, reliable images can be collected 
without studio conditions provided consistent settings are used. In this study, variability 
was controlled by avoiding the use of any built-in or external flashes and by simply 
setting the camera to white balance under fluorescent lamp, an option available on any 
commercial digital camera. This setting was also found to be advantageous in that it 
prevented a “washed-out” appearance of scars and surrounding skin colors.  
Consistent with our previous study that employed manual identification of 
fiducial points on clinical photographs [189], I found that non-clinical observers could 
delineate regions of interest surrounding scars if a minimal amount of basic training was 
provided.  However, a more automated method would be better for large outcome 
studies or for developing intra-operative tools since it took about 2 minutes to identify 
and delineate a region of interests. 
In conclusion, I found that photography can be used in place of a colorimeter for 
measuring color properties of skin in a controlled setting. I also demonstrated that 
artificial scars created by a makeup artist under the guidance of a surgeon exhibit color 
properties consistent with real scars. 
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Chapter 5: ASSESSMENT OF SURGICAL SCARS FROM CLINICAL 
PHOTOGRAPHS 
Contribution and publication: A preliminary version of the study in this chapter was 
presented at the American Medical Informatics Association Annual Symposium and a 
manuscript is being prepared for submission to a journal.  
1. M. S. Kim, W. N. Rodney, J. Peng, G. P. Reece, and M. K. Markey, "Towards 
quantifying the aesthetic outcomes of breast cancer treatment: assessing surgical scars " 




The goal of reconstructive plastic surgery of the breast is to recreate a natural 
appearance that is satisfying to the patient. However, reconstruction surgery leaves scars 
that can be disfiguring, aesthetically unpleasant, and can strongly affect a patient’s 
quality of life [151-153]. Scars can cause itching, tenderness, pain, sleep disturbances, 
anxiety, and depression. Other psychosocial problems include development of post-
traumatic stress reactions, loss of self esteem, and stigmatization [151, 152]. The 
visibility of a scar is significantly influenced by surface area, vascularity, and 
pigmentation [156]. 
In the previous chapter, assessment of skin coloration by digital photography was 
validated through statistical analyses of measurements on artificial scars. In this chapter, 
real scars were evaluated using gray scale intensity values. The gray scale value of a pixel 
is the sum of all its RGB values. Grayscale processing eliminates the need to know the 
exact relationship between RGB and observed skin color and what proportion of the 
overall color is attributable to each component. Conversion of RGB to CIE L*a*b* color 
space requires the tri-stimulus values for the light source used. However, when taking 
routine clinical photographs, most plastic surgeons do not record the specific lighting 
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conditions that control the reference parameters. Thus, while we have demonstrated that 
color assessment by photography is valid, methods that employ grayscale intensity values 
only are also of practical value.   
 
5.1.1 Surgical scar area assessment 
The applicability of simple methods to measure the size of pathological skin 
lesions has been poorly studied to date. The inter-observer reliability and accuracy 
(validity) was established for planimetry (area of a 2-D figure) by tracing on a 
photograph and planimetry by tracing on a transparent sheet in a study by Zuijilen et al. 
[162]. Drawings of 25, 50, and 75
! 
cm
2  were created on 3 locations with increasing 
curvature (back, thigh, and forearm) in 20 healthy volunteers. Three investigators 
evaluated the drawings by both planimetry techniques. Both techniques showed a good 
reliability using intraclass correlation coefficient (ICC ≥ 0.82) for 25
! 
cm
2  areas. 




2  areas and was more accurate than planimetry by transparent sheet for all 
areas except for the area with the greatest curvature, the forearm. The study permits the 
conclusion that planimetry by photography is as suitable for surface area measurements 
as planimetry by transparent sheet. 
In this study, we present results on using clinical photographs for the assessment 
of linear breast surgical scars. Digital clinical photographs were used to assess 
quantitative, objective measurements of breast surgical scars based on complete color 
intensity image analysis and area measurements. I demonstrate that the new objective 
measures utilizing clinical photographs are feasible, effective measurement methods 
using the Bland-Altman methods [191, 192]a hypothesis test for equivalence [190], and 
the ICC coefficient [173], and. 
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5.2 MATERIALS AND METHODS 
5.2.1 Datasets 
This retrospective analysis of clinical photography was approved by IRB 
protocols from The University of Texas at Austin and The University of Texas M. D. 
Anderson Cancer Center (UT MDACC). The patient population for this study was 
women aged 21 years or older who underwent Transverse Rectus Abdominis 
Myocutaneous (TRAM) breast reconstruction surgery from January 1, 1990 to June 1, 
2003 at UT MDACC. The data pool consisted of digitized images from photographs 
taken by conventional 35
! 
mm  cameras and images from digital cameras. The 
conventional photographs were digitized with a Nikon LS 2000 or Nikon Super Coolscan 
4000ED (1.06) slide digitizer. The digital cameras used were: Nikon 990 Coolpix or 
Cannon T90 35mm SLR with 50mm lens. All photographs were taken against a sky blue 
background, following guidelines on clinical photography in plastic surgery [121].  
The data set for this study consisted of 40 post-operative anterior-posterior views 
of patients.  The images were selected by an experienced plastic surgeon (GPR) and 
demonstrate a large variety of breast aesthetic characteristics, such as size, symmetry, 
ptosis, and projection. Out of the 40 anterior/posterior images used, 16 patients 
underwent conventional mastectomy followed by TRAM reconstruction and 24 patients 
had skin sparing mastectomy followed by TRAM reconstruction. Photographs of patients 
who undergo conventional mastectomy followed by TRAM (TRAM-CM) generally do 
not show the complete scar area because significant parts of scars are hidden below the 
breast mound or on the lateral side. Patients who undergo TRAM followed by a skin 
sparing mastectomy (TRAM-SSM) show no or very little flap or scarring in a standard 
photograph because the incision is made following the inframammary crease (Figure 
5.1). All regions of interest (ROIs) were manually delineated using the polygon selection 
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tool in ImageJ (NIH) by looking at the images at 400% zoom ratio on the computer 
screen with consistent resolution and size (1490×900) across the study for obtaining the 
image information. 
 
5.2.2 Measures of scar intensity (coloration) and area 
Two kinds of measurements chosen for their significant impact on scar 
assessment were calculated for each image by two observers on the same image set on 
two occasions two weeks apart. The size of the scar was computed as a ratio of the area 






















| Iscar " I flap |
I flap
            (5.3) 
 
The intensity gradient of the scar versus the surrounding normal skin was 
computed as the ratio of the absolute value of the difference in mean gray intensity of 
scar and surrounding normal regions to the average intensity of the surrounding normal 
region (NIG). This ratio provides a measure of the contrast difference between the two 
regions. For the TRAM-CM reconstructions, the intensity of the scar region was also 
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compared to that of the flap region (FIG) to investigate the contrast difference between 
the two regions.  
 
 
Figure 5.1: Sample images of regions of interest marked on clinical photographs. Top 
images show the areas of scar (left) and affected breast area (right) of patient who 
underwent conventional mastectomy followed by TRAM reconstruction. Bottom images 
show the areas of scar (left) and affected breast area (right) of patient who underwent 
skin-sparing mastectomy followed by TRAM reconstruction. For bottom images, only 
one of the patient’s two affected breasts is marked in this figure for clear illustration. 
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5.2.3 Statistical analysis 
The agreement between measurements obtained by two observers was analyzed 
separately for intensity and area. The methods used were: the Bland-Altman method 
[174, 175], a hypothesis test for equivalence [172], the ICC [173].. The Bland-Altman 
method provides a qualitative assessment while the hypothesis test for equivalence and 
ICC methods provide quantitative measures of agreement between measurements.  
 
5.2.3.1 Bland-Altman method 
The Bland-Altman method is used for qualitatively measuring the degree of 
agreement, where the differences in the measurements made by two measurements are 
plotted against the average value of these measurements. Good agreement is 
demonstrated by 95% of the differences being within ±1.96 standard deviations of the 
mean of the differences. 
 
5.2.3.2 Hypothesis test for equivalence 
In testing for equivalence between two measurements, the null hypothesis is that 
the measurements are not equivalent and the alternative hypothesis is that they are 
equivalent. This hypothesis is specifically intended for assessing equivalence and is 
distinct from that of the familiar paired t-test wherein a null hypothesis of equal value and 











x  and 
! 
"  denote the mean and standard deviation, respectively, of the 
differences between the photographic and colorimeter measurements. The value 
! 
"  is 
computed as a factor multiplied by the mean of the measurements by colorimeter. In this 
study, the factor was 0.20, 0.25, or 0.30. The variable 
! 
"  accounts for the expected 
variability in the measurements made by two methods. A smaller 
! 
"  value of implies 
stricter criteria for demonstrating that the measurements of the two methods are 
equivalent.  
 
5.2.3.3 Intraclass correlation coefficient 
To report the agreement within measurements by two observers, a single-score 
two way random model was used since the set of images is a random subset of images 
from the class of representative cases of post-operative images and observers are also 



































 is the mean square error between 
measurements.  
An average-score two way random model ICC was used for analysis of inter-
observer agreement. The average option was chosen because the averages of two 
































 is the mean square error 
between measurement methods. The guideline for interpretation of the ICC used is that 
an ICC value of less than 0.40 indicates poor reproducibility, ICC values in the range 
0.40 to 0.75 indicate fair to good reproducibility, and an ICC value of greater than 0.75 
shows excellent reproducibility [187].  
The Bland-Altman method is used for qualitatively measuring the degree of 
agreement, where the differences in the measurements made by two measurements are 
plotted against the average value of these measurements. It is demonstrated that if 95% of 
the differences are within ±1.96 standard deviations of the mean of the differences, this 
denotes good agreements between two measurement methods. 
 
5.2.4 Comparison of TRAM-CM and TRAM-SSM 
In addition to these agreement assessments, two categories of data, TRAM-CM 
and TRAM-SSM, were analyzed for the area ratio and intensity measurements to 
investigate whether any characteristic differences between two groups are present. 
 
5.3 RESULTS 
The Bland-Altman method, a hypothesis test for equivalence, and ICC were used 
to assess the degree of intra- and inter-observer variability in measurements of scar 
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coloration and surface area due to variability in manual segmentation of regions of 
interest in digital photographs. 
 
5.3.1 Intensity assessment, Intra-rater agreement 
For both observers, the degree of agreement between the two sets of color 
measurements was analyzed using the Bland-Altman method (Figure 5.2, Figure 5.3). For 
both TRAM-CM and TRAM-SSM cases, good agreement was obtained for all the 
parameters measured; 95% of the differences were within the limit of agreement.  
Using the hypothesis test for equivalence on the cases of TRAM-CM, equivalence 
was achieved between first and second color measurements (N = 16) of both observers at 
the 30% level for NIG (Observer 1: p = 0.03, Observer 2: p = 0.03) and at the 20% level 
for FIG (Observer 1: p = 0.01, Observer 2: p = 0.01), (Table 5.1). On the cases of 
TRAM-SSM, equivalence was achieved between the first and second measurements of 
NIG (N = 24) at the 20% level (Observer 1: p = 0.00, Observer 2: p = 0.00) (Table 5.2).  
The intra-observer agreement as assessed by ICC between the two sets of 
measurements made by Observer 1 on the cases of TRAM-CM was very good (Table 
5.3). For Observer 1, the intra-observer agreement was “excellent” for FIG (ICC = 0.94) 
and “fair to good” for NIG (ICC = 0.68). Similarly, for Observer 2, the intra-observer 
agreement was “excellent” for both NIG (ICC = 0.84) and FIG (ICC = 0.95). Likewise, 
the intra-observer agreement on the cases of TRAM-SSM was very good (Table 5.4). The 
intra-observer agreement for NIG on the TRAM-SSM cases was “fair to good” for 










(a) NIG – Observer 1 
 
(b) NIG - Observer 2 
 
(c) FIG – Observer 1 
 
(d) FIG – Observer 2 
Figure 5.2: Bland-Altman analysis for the intra-observer agreement for the intensity 
measurement ratios that were measured by twice by the Observer 1 and Observer 2 on 
the cases of TRAM after conventional mastectomy (TRAM-CM). The parameters 
measured were: (a) NIG-Observer 1, (b) NIG-Observer 2, (c) FIG-Observer 1, and (d) 
FIG-Observer 2. Good agreement was obtained for all the parameters measured 





(a) NIG – Observer 1 
 
(b) NIG – Observer 2 
Figure 5.3: Bland-Altman analysis for the intra-observer agreement for the intensity 
measurement ratios that were measured by twice by Observer 1 and Observer 2 on the 
cases of TRAM after skin sparing mastectomy (TRAM-SSM). The parameters measured 
were: (a) NIG – Observer 1, and (b) NIG - Observer 2. Good agreement was obtained 
for the parameter measured because 95% of the differences were within the limit of 











Table 5.1: Results of the hypothesis test for equivalence between the first and second set of measurements made by Observer 1 
and Observer 2 on the cases of TRAM after conventional mastectomy (TRAM-CM). The null hypothesis was that the two sets 
of measurements made by Observer1 and Observer 2 were not equivalent. A p-value less than 0.05 indicate that equivalence 
can be achieved between the two sets of measurements. δ = Variability factor*mean of first set of measurement. 










16 0.30 p = 0.03 p = 0.00 p = 0.03 p = 0.00 
16 0.25 p = 0.06 p = 0.00 p = 0.06 p = 0.00 




Table 5.2: Results of the hypothesis test for equivalence between the first and second set of measurements made by Observer 1 
and Observer 2 on the cases of TRAM after skin sparing mastectomy (TRAM-SSM). The null hypothesis was that the two sets 
of measurements made by Observer1 and Observer 2 were not equivalent. A p-value less than 0.05 indicate that equivalence 
can be achieved between the two sets of measurements. δ = Variability factor*mean of first set of measurement. 




Observer 2  
NIG 
16 0.30 p = 0.00 p = 0.00 
16 0.25 p = 0.00 p = 0.00 
16 0.20 p = 0.00 p = 0.00 
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Table 5.3. Intraclass correlation (ICC) coefficient for NIG and FIG ratios between the first and second set of measurements 
made by each observer on the cases of TRAM with conventional mastectomy (TRAM-CM). The intra-observer agreement was 
“excellent” for Observer 1’s FIG, Observer 2’s NIG (ICC = 0.84), and FIG (ICC = 0.95). “Fair to good” agreement was 
achieved for Observer 1’s NIG (ICC = 0.68) values. ICC value of less than 0.40 indicates poor reproducibility, ICC values in 
the range 0.40 to 0.75 indicate fair to good reproducibility, and an ICC value of greater than 0.75 shows excellent 
reproducibility. 
Number of cases (N =16) NIG FIG 
Observer 1 
 
ICC = 0.68 ICC = 0.94 




Table 5.4: Intraclass correlation (ICC) coefficient for AR and NIG ratios between the measurements made by each observer on 
the cases of TRAM with a skin sparing mastectomy (TRAM-SSM). The intra-observer agreement was “excellent” for 
Observer 2’s NIG (ICC = 0.83), while the reproducibility for Observer 1’s NIG (ICC = 0.32) was “poor”. ICC value of less 
than 0.40 indicates poor reproducibility, ICC values in the range 0.40 to 0.75 indicate fair to good reproducibility, and an ICC 
value of greater than 0.75 shows excellent reproducibility. 
Number of cases (N = 24) NIG 
Observer 1 
 
ICC = 0.61 
Observer 2 ICC = 0.83 
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5.3.2 Area Assessment, Intra-rater agreement 
For both observers, the degree of agreement between the two sets of area 
measurements was analyzed using the Bland-Altman method (Figure 5.4, Figure 5.5). For 
both TRAM-CM and TRAM-SSM cases, good agreement was obtained for all the 
parameters measured because 95% of the differences were within the limit of agreement 
following Bland-Altman’s suggestion. 
Using the hypothesis test for equivalence on the TRAM-CM cases, equivalence 
was achieved between first and second area measurements (N = 16) at the 30% level for 
Observer 1 (p = 0.03) and at the 20% level for Observer 2 (p = 0.00) (Table 5.5). For an 
equivalence level of 20%, equivalence was achieved between the first and second 
measurements (N = 24) of both observers for the measurement ratios on the cases of 
TRAM-SSM: Observer 1’s AR (p = 0.01), Observer 2’s AR (p = 0.00), (Table 5.6). 
 The intra-observer agreement between the two sets of area measurements was 
evaluated by ICC. For the area measurements made by Observer 1 on the cases of 
TRAM-CM, the agreement was “fair to good” (ICC = 0.72). The ICC was “excellent” for 
Observer 2 (ICC = 0.83), (Table 5.7). The intra-observer agreement between the two sets 
of measurements made by each observer on the cases of TRAM-SSM using the ICC 
coefficient showed mixed variability (Table 5.8). The intra-observer agreement was 
“good” for Observer 2’s AR (ICC = 0.63), while the reproducibility for Observer 1’s AR 




(a) AR - Observer 1 
 
(b) AR - Observer 2 
Figure 5.4: Bland-Altman analysis for the intra-observer agreement for area ratios that 
were measured by twice by each observer on the cases of TRAM after skin sparing 
mastectomy (TRAM-CM). The parameters measured were: (a) AR - Observer 1, (b) AR - 
Observer 2. Good agreement was obtained for the parameter measured because 95% of 
the differences were within the limit of agreement following Bland-Altman’s suggestion. 
 
(a) AR - Observer 1 
 
(c) AR - Observer 2 
Figure 5.5: Bland-Altman analysis for the intra-observer agreement for each of the two 
scar measurement ratios that were measured by twice by each observer on the cases of 
TRAM after skin sparing mastectomy (TRAM-SSM). The parameters measured were: (a) 
AR-Observer 1, (b) AR-Observer 2, Good agreement was obtained for all the parameters 
measured because 95% of the differences were within the limit of agreement following 
Bland-Altman’s suggestion. 
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Table 5.5: Results of the hypothesis test for equivalence between the first and second set of measurements made by Observer 1 
and Observer 2 on the cases of TRAM after conventional mastectomy (TRAM-CM). The null hypothesis was that the two sets 
of measurements made by Observer1 and Observer 2 were not equivalent. A p-value less than 0.05 indicate that equivalence 
can be achieved between the two sets of measurements. δ = Variability factor*mean of first set of measurement. 




Observer 2  
AR 
16 0.30 p = 0.03 p = 0.00 
16 0.25 p = 0.07 p = 0.00 




Table 5.6: Results of the hypothesis test for equivalence between the first and second set of measurements made by Observer 1 
and Observer 2 on the cases of TRAM after skin sparing mastectomy (TRAM-SSM). The null hypothesis was that the two sets 
of measurements made by Observer1 and Observer 2 were not equivalent. A p-value less than 0.05 indicate that equivalence 
can be achieved between the two sets of measurements. δ = Variability factor*mean of first set of measurement. 




Observer 2  
AR 
16 0.30 p = 0.00 p = 0.00 
16 0.25 p = 0.00 p = 0.00 
16 0.20 p = 0.01 p = 0.00 
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Table 5.7. Intraclass correlation (ICC) coefficient for AR, NIG, and FIG ratios between the first and second set of 
measurements made by each observer on the cases of TRAM with conventional mastectomy (TRAM-CM). The intraobserver 
agreement was “excellent” for Observer 2’s AR (ICC = 0.83). “Fair to good” agreement was achieved for Observer 1’s AR 
(ICC = 0.72) values. ICC value of less than 0.40 indicates poor reproducibility, ICC values in the range 0.40 to 0.75 indicate 
fair to good reproducibility, and an ICC value of greater than 0.75 shows excellent reproducibility. 
Number of cases (N =16) AR 
Observer 1 
 
ICC = 0.72 




Table 5.8: Intraclass correlation (ICC) coefficient for AR and NIG ratios between the measurements made by Observer 1 and 
Observer 2 on the cases of TRAM with a skin sparing mastectomy (TRAM-SSM). The intra-observer agreement was “good” 
for Observer 2’s AR (ICC = 0.63), while Observer unacceptable reproducibility was achieved for Observer 1’s AR (ICC = 
0.18). ICC value of less than 0.40 indicates poor reproducibility, ICC values in the range 0.40 to 0.75 indicate fair to good 
reproducibility, and an ICC value of greater than 0.75 shows excellent reproducibility. 
Number of cases (N = 24) AR 
Observer 1 
 
ICC = 0.87 
Observer 2 ICC = 0.63 
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5.3.3 Intensity assessment, Inter-rater agreement 
The inter-observer agreement in the color assessments made based on the manual 
segmentations by the two observers was analyzed using the Bland-Altman method 
(Figure 5.6). For both TRAM-CM and TRAM-SSM cases, good agreement was obtained 
for all the parameters measured because 95% of the differences were within the limit of 
agreement following Bland-Altman’s suggestion. 
Using the hypothesis test for equivalence to assess the inter-observer variability in 
NIG for TRAM-CM cases (N = 16), the results were only borderline for statistical 
significance at the 30% level (p = 0.05). In comparison, inter-observer equivalence was 
achieved for FIG on the TRAM-CM cases at the 20% level (p = 0.01). For the TRAM – 
SSM (N = 24) cases, inter-observer equivalence in NIG was achieved at the 30% level (p 
= 0.03) (Table 5.9). 
The inter-observer agreement between the color measurements made by Observer 
1 and Observer 2 on the cases of TRAM-CM was also assessed using ICC. The inter-
observer agreement on TRAM-CM cases was “fair to good” for NIG (ICC = 0.50) and 
“excellent” for FIG (ICC = 0.95). Similarly, for TRAM-SSM cases, the inter-observer 











(a) TRAM-CM, NIG 
 
 
(b) TRAM-CM, FIG 
 
(c) TRAM-SSM, NIG 
Figure 5.6: Bland-Altman analysis for the 
inter-observer agreement between Observer 1 
and Observer 2 for each of the three scar 
measurement ratios that were measured on 
the cases of TRAM after conventional 
mastectomy (TRAM-CM) and on the cases of 
TRAM after skin sparing mastectomy 
(TRAM-SSM). The parameters measured 
were: (a) TRAM-CM, NIG, (b) TRAM-CM, 
FIG, and (c) TRAM-SSM, NIG. Good 
agreement was obtained for all the 
parameters measured because 95% of the 
differences were within the limit of 




Table 5.9: Results of the hypothesis test for equivalence between the observers on the cases of TRAM with conventional 
mastectomy (TRAM-CM) and on the cases of TRAM after a skin-sparing mastectomy (TRAM-SSM). The null hypothesis was 
that the measurements made by Observer1 and Observer 2 were not equivalent. A p-value less than 0.05 indicate that 
equivalence can be achieved between the measurements by two observers. δ = Variability factor*mean of first set of 
measurement. 
 TRAM-CM (N=16) TRAM-SSM (N=24) 
Variability factor NIG FIG NIG 
0.30 p = 0.05 p = 0.00 p = 0.03 
0.25 p = 0.08 p = 0.00 p = 0.06 
0.20 p = 0.12 p = 0.01 p = 0.11 
 
 
Table 5.10: Intraclass Correlation Coefficient (ICC) for NIG and FIG measurement ratios between Observer 1 and Observer 2 
on the cases of TRAM with conventional mastectomy (TRAM-CM) and on the cases of TRAM with skin sparing mastectomy 
(TRAM-SSM). ICC value of less than 0.40 indicates poor reproducibility, ICC values in the range 0.40 to 0.75 indicate fair to 
good reproducibility, and an ICC value of greater than 0.75 shows excellent reproducibility. 
TRAM-CM (N=16)  TRAM-SSM (N=24) 
NIG FIG NIG 
ICC = 0.50 ICC = 0.95 ICC = 0.62 
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5.3.4 Area assessment, Inter-rater agreement 
The inter-observer agreement in the area measurements made based on the 
manual segmentations of the two observers was analyzed using the Bland-Altman 
method (Figure 5.7). For both TRAM-CM and TRAM-SSM cases, good agreement was 
obtained for all the parameters measured because 95% of the differences were within the 
limit of agreement following Bland-Altman’s suggestion.  
The inter-observer agreement in the area measurements was also evaluated using 
the hypothesis test for equivalence (Table 5.11). For the TRAM-CM cases (N = 16), 
equivalence between the areas measurements based on the ROIs identified by the two 
observers was achieved at the 20% level (p = 0.00). Likewise, for the TRAM-SSM cases 
(N = 24), equivalence between the areas measurements based on the ROIs identified by 
the two observers was achieved at the 20% level (p = 0.04).  
As evaluated by ICC, the inter-observer agreement between the area 
measurements made by Observer 1 and Observer 2 on the cases of TRAM-CM was 
“excellent” (ICC = 0.81) and FIG (ICC = 0.95) (Table 5.12). “Fair to good” agreement in 










(a) TRAM-CM, AR 
 
(b) TRAM-SSM, AR 
Figure 5.7: Bland-Altman analysis for the inter-observer agreement in AR between 
Observer 1 and Observer 2 on the cases of TRAM after skin sparing mastectomy (TRAM-
SSM) and on the cases of TRAM after skin sparing mastectomy (TRAM-SSM). Good 
agreement was obtained because 95% of the differences were within the limit of agreement 




Table 5.11: Results of the hypothesis test for equivalence between the observers on the cases of TRAM after conventional 
mastectomy (TRAM-CM) and on the cases of TRAM after a skin-sparing mastectomy (TRAM-SSM). The null hypothesis was 
that the measurements made by Observer 1 and Observer 2 were not equivalent. A p-value less than 0.05 indicate that 
equivalence can be achieved between the measurements by two observers. δ = Variability factor*mean of first set of 
measurement. 
 TRAM-CM (N=16) TRAM-SSM (N=24) 
Variability factor AR AR 
0.30 p = 0.00 p = 0.03 
0.25 p = 0.00 p = 0.03 
0.20 p = 0.00 p = 0.04 
 
 
Table 5.12. Intraclass correlation (ICC) coefficient for AR measurement ratios between Observer 1 and Observer 2 on the 
cases of TRAM with conventional mastectomy (TRAM-CM) and on the cases of TRAM with skin sparing mastectomy 
(TRAM-SSM). 
TRAM-CM (N=16) TRAM-SSM (N=24) 
AR AR 
ICC = 0.81 ICC = 0.68 
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5.3.5 Comparison of TRAM-CM and TRAM-SSM 
In addition to the agreement assessments, two categories of data, TRAM-CM and 
TRAM-SSM, were analyzed for the area ratio and intensity measurements to investigate 
whether there present any characteristic differences between two groups (Table 5.13). 
One reason for these differences is that the identification of an ROI of “normal” skin 
seemed to be more variable than for identifying “flap” skin. Two-sample t-test was 
performed to analyze the difference between the ratio values of these two groups. The 
results of AR measurements showed that the proportion of the breast area affected by 
scarring is statistically significantly larger (p = 0.01) for TRAM-CM (overall mean = 
0.05) than for TRAM-SSM (overall mean: 0.03). This result is consistent with our 
expectation that larger skin flap introduce larger scar regions. The results of intensity 
measurements showed that intensity gradient between the scars and surrounding normal 
scars were statistically significantly greater (p = 0.00) in TRAM-SSM (overall NIG = 
0.21) than that of TRAM-CM (overall NIG = 0.11). When the two intensity 
measurements within TRAM-CM were compared, the intensity gradient between scars 
and flap (overall FIG = 0.17) were greater than that between scars and surrounding 
normal skin area (overall NIG = 0.11, but the result was not statistically significant (p = 
0.78). The possible explanation for this result is that significant amount of scars on the 
cases of TRAM-CM, most of the breast skin is replaced with transported skin from 
abdominal area which were not affected by breast cancer treatments such as radiation 
therapy which may make skin appear tan or red, while most of the skin is preserved on 
the cases of TRAM-SSM. 
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Table 5.13: Results of the AR values by the observers on the cases of TRAM after a 
conventional mastectomy (TRAM-CM, N = 16) and on the cases of TRAM after a skin-
sparing mastectomy (TRAM-SSM, N = 24).  
Observer TRAM-CM (N=16)         TRAM-SSM (N=24) 













Overall 0.05 0.11 0.17 0.03 0.21 
 
5.4 DISCUSSION AND CONCLUSION 
Breast surgery leaves scars that can be disfiguring, aesthetically unpleasant, and 
can strongly affect a patient’s quality of life. Current assessments of surgical scars require 
employment of mechanical, electronic, or chemical measurements that are expensive and 
time consuming or employment of qualitative observer ratings based on direct viewing of 
patients and which have low intra- and inter- observer agreement. Quantitative as well as 
effective measurement methods are required to investigate the relationships between 
patient and surgical variables and aesthetic outcomes.  
In this chapter, I presented results of using clinical photographs for the assessment 
of color and area information of linear breast surgical scars. Digital photography has 
already been widely utilized in the plastic and reconstructive surgery field for record 
keeping purposes. I investigated intra-and inter-reliability of the measurements in 
TRAM-CM and TRAM-SSM groups using the Bland-Altman method [191, 192], a 
hypothesis test for equivalence [190], the ICC coefficient [173]. The results showed no 
statistical difference between and within two non-clinical observers in the two measures 
using photographs of real scars.  
Based on the fair to excellent reliability for most of the measurement methods 
achieved in the assessment, two categories of data, TRAM-CM and TRAM-SSM, were 
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also analyzed s to see if there are any characteristic differences in the area ratio and 
intensity measurements between the two groups. The AR measurement suggests that 
breast area affected by scarring is larger for TRAM-CM than for TRAM-SSM, which is 
consistent with expectations due to the skin-sparing procedure using a smaller flap in 
reconstruction and involving a smaller perimeter. The results of intensity measurements 
of the TRAM-CM show that the intensity gradient between scar and flap is greater than 
between scar and normal skin. This result implies that the scar appears more visible when 
compared to the flap skin than when compared to the normal skin in the area. However, 
the TRAM-SSM showed larger intensity gradients between scar and normal skin than 
those found for the scar and flap of TRAM-CM.  
Two important points for future studies of surgical scar assessment by digital 
photography should be noted. First, standardized photography is critical for reliable 
photographic assessment of scars. Even though the data used in this study were collected 
following the current photographic standards [121], the authors still had difficulty in 
delineating scar regions on some patient images because of varying lighting intensity, 
distance and direction from the light to the subject, camera lighting settings, background 
color, and a subject’s pose in relation to a camera. Second, all pertinent information on 
the photographic conditions, including the tri-stimulus values of the light source, should 
be recorded. Likewise, thorough clinical information accompanying the clinical 
photographs will help clinicians understand the measurement results. 
 110 
This study presented encouraging findings and suggests that objective quantitative 
measures for assessing surgical scars can be computed. Further study employing large 
patient cases will be necessary to confirm the results of this study.  
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Chapter 6: DEVELOPMENT OF OBSERVER RATING SCALE FOR 
THE ASSESSMENT OF BREAST AESTHETICS 
Contribution and publication: The study in this chapter is ongoing under the guidance of 
an experienced behavioral scientist Dr. Basen-Engquist (Behavioral Science, UT 
MDACC). 
6.1 INTRODUCTION 
While a human observer’s rating assessment of the aesthetic outcome is not as 
reliable as an objective measure would be, it is the method most commonly used at this 
time (Chapter 2). However, although prior studies have used an observer rating scale for 
breast aesthetics, there is not a standard, accepted scale. Moreover, there are problems 
with the existing scales. First, most of the scales are extremely vague. Second, most focus 
only on one or two aesthetic properties (e.g., symmetry) and so provide a very limited 
measure of aesthetics. Third, most of the scales were devised with breast conservation 
therapy in mind and can’t be directly used to assess the outcomes of other surgeries, such 
as reconstruction procedures.  
We are developing an observer rating scale following social science guidelines for 
scale construction [193-195], under the guidance of an experienced behavioral scientist 
Dr. Basen-Engquist (Behavioral Science, UT MDACC). The purpose is to enable plastic 
surgeons to subjectively, but reliably, describe breast anatomy. The wide-spread adoption 
of the lexicon would help standardize the terminology used to report the aesthetic 
outcomes of reconstructive surgery and improve communication between reconstructive 
surgeons and radiation oncologists. 
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6.2 FRAMEWORK FOR RATING SYSTEM DEVELOPMENT  
While many previous studies have employed a single-item overall assessment of 
aesthetics, a multi-item scale is typically recommended for complex phenomena. We 
began by generating a large pool of potential items through “brainstorming” sessions. At 
the same time, we discussed possible question formats and the number of response 
categories. After generating a pool of items, we rated them for relevance and clarity so as 
to choose a reasonable number for use. We collected audio recordings of our scale 
construction meetings so that we can answer questions that may later arise about the scale 
construction process. 
Two important properties of a scale are validity and reliability [193-195]. The 
content validity of our rating system is established by the involvement of reconstructive 
surgeons throughout the scale construction process. We are quantifying the reliability of 
our rating system using the Intraclass Correlation Coefficient (ICC).  
Important design criteria for producing reliable subjective scales are clarity and 
explicitness [193]. The lexicon of breast aesthetic terminology and assessment format is 
meant to standardize the language used to report the observer assessment of aesthetic 
outcomes in reconstructive surgery and improve communication between reconstructive 
surgeons and radiation oncologists. Thus, the descriptions of the levels of the scale items 
will include text, idealized line drawings, and actual photographic examples. A 
preliminary version of the lexicon is presented in section 6.3. 
 
6.2.1 Data collection 
Three experienced plastic surgeons at UT MDACC used the preliminary lexicon 
to rate 32 patient cases using a web-based interface. This web-based interface was also 
used to display the clinical images and collect observer ratings of aesthetics during the 
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eye-tracker experiments (Figure 6.1). Five images of each patient are displayed: an 
anterior-posterior and lateral and oblique views of both the right and left breasts. The 
oblique views are taken at an angle of about 45 degrees from the true lateral. The vertical 
extent of the views is from just below the chin down to the top of the pubic bone. The 
oblique views are taken at an angle of about 45 degrees from the true lateral. All images 
were displayed on a LCD monitor using the Internet Explorer (© Microsoft Corporation) 
browser. 
 
6.2.2 Evaluation of preliminary lexicon 
In addition to validity and reliability, it is important to confirm that different 
observers can consistently use our rating system. Repeatability is being assessed by 
determining the agreement in using the rating system between different observers and 
over time. As an initial step toward to this evaluation process, six fellows at UT MDACC 
who weren’t involved in designing the rating system rated 13 selected cases using the 
same web-based interface the plastic surgeons used. ICC was used to measure intra- and 
inter-rater agreement. We standardized the reading conditions as much as possible. For 
example, all of the observers viewed the cases using the same computer facility in the 
department.  
In addition to assess repeatability of the scale, we have been evaluating the 
lexicon to generate explicit terminology. As a preliminary evaluation process, we found 
that items about breast shape are important. Two plastic surgeons rated the top-six most 
influential rating items selected from a preliminary breast aesthetic rating instrument for 
eye-tracking study (Refer Ch 7). The goal of this study was to understand how plastic 
surgeons assess breast aesthetics by using eye-tracking technology to record their gaze 
path while they rate breast anatomy on clinical photographs. The rating items used were: 
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(1) initial impression of overall appearance of the breasts, from 0 indicating very poor to 
10 indicating excellent, (2) symmetry of size of breast mounds (3) symmetry of shape of 
breast mounds, (4) aesthetic shape (5) natural shape and (6) final impression of overall 
appearance of the breasts.  
More work should be done to develop explicit observer rating scale to rate full 
range of breast aesthetics based on patients’ opinions as well as the knowledge of 
experienced reconstructive surgeons. Both the observer rating scale and quantitative 
methods should be assessed for the intra- and inter-observer variability against each other 
using rating data collected by more reconstructive surgeons and patients not involved in 







Figure 6.1: This image illustrates an example of a patient case displayed while an 
observer examined a case to rate the initial impression of the overall appearance of the 
breasts. The observer rated this case on the 11-point scale, where 0 indicates very poor 
and 10 indicates excellent. Five images are displayed from each patient: an anterior-
posterior (AP) and lateral and oblique views of both the right and left breasts. A specific 
item is displayed at the same time the images are displayed. Clicking on question mark at 







6.3 PRELIMINARY OBSERVER RATING SCALE 
The observer rating scale consists of 11 symmetry ratings items, 14 individual 
breast ratings items, and a global rating on overall appearance before and after the entire 
rating items. To rate the symmetry rating items, observer should select a rating from a 
point scale or Y/N. If the observer feel this item cannot be properly rated, he/ she can 
select “N/A”. Similarly, observer should select a rating from a point scale or Y/N, but 
should rate both breasts separately. Each rating scale is explained with the lexicon 
prepared to help standardize the terminology used to report the subjective assessment of 
aesthetic outcomes in reconstructive surgery and improve communication between 
reconstructive surgeons and radiation oncologists.  
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        Excellent 
N/A 0 1 2 3 4 5 6 8 9 10 
 
Description: this scale rates your initial impression of the overall appearance of 
the breasts from an aesthetic point of view.  
 
The scale of the initial impression is based on a rating from 0 (a very poor 
impression of the overall appearance of the breasts) to 10 (an excellent 
impression of the overall appearance of the breasts).  
 
If you feel this item cannot be properly rated, select “N/A”. You will be prompted 




6.3.2 Symmetry ratings 





         Completely 
symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the size of the breast 
mounds, irrespective of the composition of the skin of the breast, i.e., native 
breast skin, flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the size of one breast mound is severely 
asymmetrical to the size of the opposite breast mound) to 10 (the sizes of the 
breast mounds are completely symmetrical).  
 
To rate the symmetry of the size of the left and right breast mounds, select a 
rating from 0 to 10. If you feel this item cannot be properly rated, select “N/A”. 
You will be prompted to explain this selection, e.g., cannot rate symmetry 
because left breast is missing. 
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         Completely 
Symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the shape of the breast 
mounds, irrespective of the composition of the skin of the breast, i.e., native 
breast skin, flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the shape of one breast mound is severely 
asymmetrical to the shape of the opposite breast mound) to 10 (the shapes of 
the breast mounds are completely symmetrical).  
 
To rate the symmetry of the shape of the left and right breast mounds, select a 
rating from 0 to 10. If you feel this item cannot be properly rated, select “N/A”. 
You will be prompted to explain this selection, e.g., cannot rate symmetry 
because left breast is missing. 
 
 120 




         Completely 
Symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
 
Description: this scale compares the symmetry of the lowest visible point of one 
breast to the lowest visible point of the contralateral or opposite breast, 
irrespective of the composition of the skin of the breast, i.e., native breast skin, 
flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the lowest visible point of one breast is 
severely asymmetrical to the lowest visible point of the opposite breast) to 10 
(the lowest visible points of the breasts are completely symmetrical).  
 
To rate the symmetry of the lowest visible point of the left and right breasts, 
select a rating from 0 to 10. If you feel this item cannot be properly rated, select 
“N/A”. You will be prompted to explain this selection, e.g., cannot rate symmetry 
because left breast is missing. 
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         Completely 
Symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the skin color of the breast 
mounds, irrespective of the composition of the skin of the breast, i.e., native 
breast skin, flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the skin color of one breast is severely 
asymmetrical to the skin color of the opposite breast) to 10 (the skin color of the 
breasts is completely symmetrical). An area of skin with markedly different color 
would indicate poor symmetry. 
 
To rate the symmetry of the skin color of the left and right breast, select a rating 
from 0 to 10. If you feel this item cannot be properly rated, select “N/A”. You will 
be prompted to explain this selection, e.g., cannot rate symmetry because left 
breast is missing. 
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         Completely 
Symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the position of the 
nipple/areola complex (NAC) relative to the position of the NAC of the 
contralateral or opposite breast, irrespective of the composition of the skin of the 
breast, i.e., native breast skin, flap skin, or some combination of the two types of 
skin.  
 
The scale is based on a rating from 0 (The position of the NAC on one breast is 
severely asymmetrical to the position of the NAC of the opposite breast) to 10 
(The position of the NAC on one breast is completely symmetrical to the position 
of the NAC of the opposite breast).  
 
To rate the symmetry of NAC relative to midline, select a rating from 0 to 10. If 
you feel this item cannot be properly rated, select “N/A”. You will be prompted to 
explain this selection, e.g., cannot rate symmetry because left breast is missing. 
 
 123 




         Completely 
symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the position of the nipple of 
one breast to the position of the nipple of the contralateral or opposite breast, 
irrespective of the composition of the skin of the breast, i.e., native breast skin, 
flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the position of the nipple of one breast is 
severely asymmetrical to the position of the nipple of the opposite breast) to 10 
(the position of the nipple is completely symmetrical to the position of the nipple 
of the opposite breast).  
 
To rate the symmetry of position of the left and right nipples, select a rating from 
0 to 10. If you feel this item cannot be properly rated, select “N/A”. You will be 








         Completely 
Symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the position of the areola of 
one breast relative to the position of the areola of the contralateral or opposite 
breast, irrespective of the composition of the skin of the breast, i.e., native breast 
skin, flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (The position of the areola of one breast is 
severely asymmetrical to the position of the areola of the opposite breast) to 10 
(The position of the areola of one breast is completely symmetrical to the position 
of the areola of the opposite breast).  
 
To rate the symmetry of areolar positions, select a rating from 0 to 10. If you feel 
this item cannot be properly rated, select “N/A”. You will be prompted to explain 
this selection, e.g., cannot rate symmetry because left breast is missing. 
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         Completely 
symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the diameter of the nipple of 
one breast to the diameter of the nipple of the contralateral or opposite breast, 
irrespective of the composition of the skin of the breast, i.e., native breast skin, 
flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the diameter of the nipple of one breast is 
severely asymmetrical to the diameter of the nipple of the opposite breast) to 10 
(the diameter of the nipple is completely symmetrical to the diameter of the nipple 
of the opposite breast).  
 
To rate the symmetry of diameters of the left and right nipples, select a rating 
from 0 to 10. If you feel this item cannot be properly rated, select “N/A”. You will 
be prompted to explain this selection, e.g., cannot rate symmetry because left 
breast is missing. 
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         Completely 
symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the diameter of the areola of 
one breast relative to the diameter of the areola of the contralateral or opposite 
breast, irrespective of the composition of the skin of the breast, i.e., native breast 
skin, flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (The diameter of the areola of one breast is 
severely asymmetrical to the diameter of the areola of the opposite breast) to 10 
(The diameter of the areola of one breast is completely symmetrical to the 
diameter of the areola of the opposite breast). If the areolae are not exactly 
circular, consider the average diameters. 
 
To rate the symmetry of areolar diameters, select a rating from 0 to 10. If you feel 
this item cannot be properly rated, select “N/A”. You will be prompted to explain 
this selection, e.g., cannot rate symmetry because left breast is missing. 
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         Completely 
symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the color of the nipple of one 
breast to the color of the nipple of the contralateral or opposite breast, 
irrespective of the composition of the skin of the breast, i.e., native breast skin, 
flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the color of the nipple of one breast is 
severely asymmetrical to the color of the nipple of the opposite breast) to 10 (the 
color of the nipple is completely symmetrical to the color of the nipple of the 
opposite breast).  
 
To rate the symmetry of color of the left and right nipples, select a rating from 0 
to 10. If you feel this item cannot be properly rated, select “N/A”. You will be 








         Completely 
symmetrical 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the symmetry of the color of the areola of one 
breast to the color of the areola of the contralateral or opposite breast, 
irrespective of the composition of the skin of the breast, i.e., native breast skin, 
flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the color of the areola of one breast is 
severely asymmetrical to the color of the areola of the opposite breast) to 10 (the 
color of the areola is completely symmetrical to the color of the areola of the 
opposite breast).  
 
To rate the symmetry of color of the left and right areolae, select a rating from 0 
to 10. If you feel this item cannot be properly rated, select “N/A”. You will be 




6.3.3 Individual ratings 




    Just  
Right 
   Too 
Large  
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale rates your impression of the overall size of each breast 
relative to the size of the patient’s visible torso (trunk).  
 
The scale of the overall breast size is based on a rating from 0 (breast is too 
small relative to the visible torso) to 10 (the breast appears too large relative to 
the visible torso) with a rating of 5 equal to the breast size is just right relative to 
the visible torso.  
 
This item is rated separately for the left and right breasts. If you feel this item 
cannot be properly rated, select “N/A”. You will be prompted to explain this 
selection, e.g., cannot rate it because left breast is missing. 
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6.3.3.2 Ptosis and Pseudoptosis 
 
Description: the scale is the current system that is accepted and used by most 
surgeons to rate the degree of breast droopiness or sagging from the chest wall. 
The ptosis scale is based on the location of the nipple relative to the level of the 
inframammary fold (IMF) while the presence of absence of pseudoptosis relates 
to whether the breast tissue is located above or below the level of the IMF with 
the nipple above the IMF. The figures on the following pages give a visible and 




Ptosis is rated separately for each breast. To rate the extent of ptosis for a 
breast, select a rating from 0 to 3. If you feel this item cannot be properly rated, 
select “N/A”. You will be prompted to explain this selection, e.g., cannot rate item 
because left breast is missing. 
 
 No Ptosis  Minor Ptosis Moderate 
Ptosis 
Major Ptosis 




Pseudoptosis is rated separately for each breast. To rate the presence or 
absence of pseudoptosis, select a rating of Y (yes) or N (no). If you feel this item 
cannot be properly rated, select “N/A”. You will be prompted to explain this 
selection, e.g., cannot rate item because left breast is missing. 
 






Grade 0 Grade 1 Grade 2 Grade 3 
Figure 6.2: Sample images (right lateral view) illustrating the ptosis grades described by 




6.3.3.3 Isolated contour deformity 
 
Description: this scale rates the severity of a contour deformity by its location in 
a specific section on each breast. A contour deformity is a focal or isolated area 
where there is a deviation of the expected contour for one or more sections of the 
breast. These contour deviations include a focal area of excessive tissue, a dent, 
a depression or some combination of these characteristics.  
 
The scale is rated from 0 (there is a marked contour deformity) to 10 (there is no 
contour deformity). A value is selected for each of Superior Medial, Superior 
Lateral, Inferior Medial, and Inferior lateral regions of each breast. The quadrants 
are defined relative to the nipple areolar complex as shown below.  
 
If you feel this item cannot be properly rated, select “N/A”. You will be prompted 
to explain this selection, e.g., cannot rate item because left breast is missing. 
 
  
  Marked  
Contour  
Deformity 
   No  
Contour 
Deformity 



















Definition of quadrants of the breasts: The larger outer circle represents the 
breast. The smaller inner circle represents the areola with the crosshairs 

















Right Breast  Left Breast  
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 6.3.3.4 Contour of breasts 
 
Description: this scale rates the deviation of the contour relative to the perfect or 
ideal contour for a specific section on each breast.  
 
The scale is rated from 0 (the section is markedly deficient in volume relative to 
the perfect volume contour for that section) to 10 the section is overly full in 
volume relative to the perfect volume contour for that section) with 5 (the section 
has perfect contour).  
 
A value is selected for each of Superior Medial, Superior Lateral, Inferior Medial, 
and Inferior lateral regions of each breast. The quadrants are defined relative to 
the nipple areolar complex.  
 
If you feel this item cannot be properly rated, select “N/A”. You will be prompted 
to explain this selection, e.g., cannot rate item because left breast is missing. 
 
   
 Markedly 
Deficient  
  Perfect  Overly  
Full 










Definition of quadrants of the breasts: The larger outer circle represents the 
breast. The smaller inner circle represents the areola with the crosshairs 


















Right Breast  Left Breast  
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6.3.3.5 Natural shape 
 
 Very unnatural  
shape 
   Very natural  
shape 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale rates your impression of the overall natural appearance 
of the shape of each breast.  
 
The scale of the naturally shaped breast is based on a rating from 0 (a very 
unnatural shape of the breast) to 10 (a very natural shape of the breast).  
 
A natural shaped breast should be compatible with the native breast. The breast 
should not look surgically altered nor have the appearance of a breast 
augmentation, reduction, or mastopexy. Some characteristics of an unnaturally 
shaped breast are superior pole fullness, elements of a distorted contour, and 
excessively round contours. 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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6.3.3.6 Scars - Overall appearance relative to surrounding skin 
 
 Very obvious, 
noticeable 
    No visible  
scars 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the overall appearance of the scars of a breast 
to the skin of that breast, irrespective of the composition of the skin of the breast, 
i.e., native breast skin, flap skin, or some combination of the two types of skin.  
 
The scale is based on a rating from 0 (the overall appearance of the scars is very 
obvious and noticeable relative to the skin of the breast) to 10 (there are no 
visible scars on the breast).  
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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6.3.3.7 Scars - Thickness relative to surrounding skin 
 
 Very  
thick  
scar 




N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the thickness (vertical height) of the scars of a 
breast to the level of the skin of that breast, irrespective of the composition of the 
skin of the breast, i.e., native breast skin, flap skin, or some combination of the 
two types of skin.  
 
The scale is based on a rating from 0 (the scar is a very thick scar compared to 
the level of the skin of the breast) to 10 (the scar is lower in vertical height 
compared to the level of the breast skin).  
 
Scar thickness refers to the vertical height of the scar relative to surrounding skin 
(e.g., a hypertropic scar would be a very thick scar). 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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6.3.3.8 Scars - Width relative to surrounding skin 
 
 Very  
wide  
scar 
 Moderate  Thin scar 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: Some scars vary in width along their course, but this scale is used 
to rate the overall width of the scars on the breast, i.e., the overall spread of the 
scar on the breast skin.  
 
This scale compares the overall width of the scars of a breast, irrespective of the 
composition of the skin of the breast, i.e., native breast skin, flap skin, or some 
combination of the two types of skin.  
 
The scale is based on a rating from 0 (the scars is a very wide scar on the skin of 
the breast) to 10 (the scar is very thin and barely noticeable on the breast skin). 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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6.3.3.9 Scars - Color relative to surrounding skin 
 








N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the color of the scars of a breast to the color of 
the skin of that breast, irrespective of the composition of the skin of the breast, 
i.e., native breast skin, flap skin, or some combination of the two types of skin. 
 
The scale is based on a rating from 0 (the color of the scars is a very different 
color from the color of the skin around the breast) to 10 (the color of the scars is 
a very similar color from the color of the skin around the breast). 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
 
 139 








N/A 0 1 2 3 4 5 6 7 8 9 10 
 
 
Description: this scale compares the diameter of the nipple of a breast to the 
size of the breast, itself.  
 
The scale is based on a rating from 0 (the diameter of the nipple is much too 
small relative to the size of the breast) to 10 (the diameter of the areola is much 
too large relative to the size of the breast) with a rating of 5 indicating that the 
diameter of the nipple relative to the breast size is just right. 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale compares the diameter of the areola of a breast to the 
size of the breast, itself.  
 
The scale is based on a rating from 0 (the diameter of the areola is much too 
small compared to the size of the breast) to 10 (the diameter of the areola is 
much too large compared to the size of the breast) with a rating of 5 indicating 
that the diameter of the areola relative to the breast size is just right. 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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6.3.3.12 Coloration of nipple relative to color of areola 
 
 Much too 
light 
 Just  
right 
 Much too 
dark 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
 
Description: this scale compares the color of the nipple of a breast to the color 
of the areola around the nipple of that breast, irrespective of the composition of 
the skin of the nipple and/or the areola, i.e., native breast skin, flap skin, or some 
combination of the two types of skin.  
 
The scale is based on a rating from 0 (the color of the nipple is much too light 
compared to the color of the areola of the breast) to 10 (the color of the nipple is 
much too dark compared to the color of the areola of the breast) with 5 (the color 
of the nipple is just right compared to the color of the areola of the breast). 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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6.3.3.13 Coloration of areola relative to surrounding skin 
 
 Much too 
light 
 Just  
right 
 Much too 
dark 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
 
Description: this scale compares the color of the areola of a breast to the color 
of the skin around the areola of that breast, irrespective of the composition of the 
skin of the breast, i.e., native breast skin, flap skin, or some combination of the 
two types of skin.  
 
The scale is based on a rating from 0 (the color of the areola is much too light 
compared to the color of the skin around that areola of the breast) to 10 (the 
color of the areola is much too dark compared to the color of the skin around that 
areola of the breast) and 5 (the color of the areola is just right compared to the 
color of the skin around the areola. 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 
cannot rate item because left breast is missing. 
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6.3.3.14 Projection of nipple relative to surrounding skin 
 
 None  Just  
right 
 Excessive 
N/A 0 1 2 3 4 5 6 7 8 9 10 
 
Description: this scale rates the projection of the nipple of a breast relative to 
the level of the skin around the nipple of that breast.  
 
The scale is based on a rating from 0 (there is no projection of the nipple relative 
to the level of the skin around that nipple of the breast) to 10 (the projection of 
the nipple is too excessive relative to the level of the skin around that nipple of 
the breast) with a value of 5 indicating that the nipple projection is just right 
relative to the level of the surrounding skin. 
 
This item is rated separately for each breast. If you feel this item cannot be 
properly rated, select “N/A”. You will be prompted to explain this selection, e.g., 




Chapter 7: UNDERSTANDING SURGEONS’ ASSESSMENTS OF 
THE AESTHETIC OUTCOME OF BREAST CANCER TREATMENT 
USING EYE-TRACKING 
Contribution and publication: the study in this chapter has been submitted for 
consideration of presentation at a conference on medical image perception.  
7.1 INTRODUCTION 
As described in Chapter 6, we are developing an observer rating scale under the 
leadership of an experienced behavioral scientist Dr. Basen-Engquist (Behavioral 
Science, UT MDACC) to enable plastic surgeons to subjectively, but reliably, describe 
breast anatomy. During the discussions to generate items for the breast aesthetics 
observer rating scale, it became apparent that it is challenging for observers to verbalize 
what they are looking for or even to be conscious of how they assess aesthetic properties. 
The goal of this study was to understand how plastic surgeons assess breast aesthetics by 
using eye-tracking technology to record their gaze path while they rate breast anatomy on 
clinical photographs (Figure 7.1). 
To gain an understanding of what the eye is naturally attracted to, studies 
examining visual attention on image were reviewed [196]. In recent models, visual 
attention is broken down into localized analysis problems. Neurons at the earliest stages 
of processing are tuned to visual attributes including contrast, intensity, color contrast, 
orientation, direction, spatial frequency, and velocity of motion. Because recognition and 
identification of visual stimuli take place at the same time as visual attention (though in 
different parts of the brain), it is assumed that the surgeon in the experiment can quickly 
recognize abnormalities and focus his/her attention on those features instead of features 





Figure 7.1: The image shows an example of desktop eye-tracking equipment from 
Applied Science Laboratories (Bedford, MA), which can unobtrusively collect eye-
position data while a subject examines an image presented on the computer screen.  
 
Eye-tracking has been used to help understand medical image perception. 
Numerous of studies have been conducted on the visual search processes of radiologists. 
Among these include an experiment studying the affect of lesion conspicuity on the 
visual search strategy of radiologists’ in mammogram reading [197], one studying visual 
scanning patterns and the relationship between duration of gaze at lesion and correct 
diagnosis of it [198], one comparing the relationship between lesion subtlety and 
detection of the lesion [199], and another study using an artificial neural network to 
predict radiologists’ diagnosis using spatial frequency representation of regions [200]. All 
these studies focus on understanding the visual search pattern and the resulting accuracy 
in mammogram. By comparison, I am unaware of any previous studies in plastic surgery 
that employed eye-tracking technology were unexplored. Thus, there is a clear 
opportunity to introduce this powerful methodology to a new clinical research area. 
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7.2 MATERIALS AND METHODS  
7.2.1 Eye-tracker 
An Applied Science Laboratories (Bedford, MA) Eye-Tracking System (Model 
504) was used to track the gaze of plastic surgeons at the Behavioral Research and 
Treatment Center at The University of Texas M. D. Anderson Cancer Center (UT 
MDACC) (Figure 7.1). I was trained using identical equipment in the LIVE Laboratory at 
UT Austin. The research coordinator based at UT MDACC (Angela Burgess) and I 
conducted the eye tracking experiments at UT MDACC. The Model 504 eye tracker is an 
optional magnetic head tracker where the eye is illuminated by the beam from near 
infrared LED’s on the pan/tilt optics module. An auto-focusing lens system in the pan/tilt 
module focuses a telephoto image of the eye onto a video sensor (eye-camera). The 
pan/tilt mechanism can rotate the illumination source in order to follow the eye as the 
subject moves his/her gaze. According to the specifications provided by the eye-tracker 
manufacturer, the measurable field of view is about 25 degrees visual angle to either side 
of the optics, about 25 degrees above the optics and about 10 degrees below the optics.  
Precision refers to how closely individual measurements agree with each other. The 
precision of the Model 504 eye tracker is better than 0.5 degrees of the visual angle, 
which corresponds to a circle of 0.55 cm (1/4 inch) in radius on the monitor which 
displays the image at a viewing distance of 63.5 cm (25 inch). Accuracy refers to how 
closely a measured value agrees with the correct value. The accuracy between the true 
eye position and the computed measurement is less than 1 degree of the visual angle 
1.11cm (1/2 inch), which corresponds to a circle of 0.11cm in radius on the monitor 
under the viewing conditions defined above (Figure 7.2). 
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Figure 7.2: This image illustrates the accuracy of the eye-tracker ASL 540. This model 
has a accuracy of 1 degree in visual angle which is represented as a circle with 1.11 cm  
(½ inch) in radius.  
 
7.2.2 Calibration 
In the setup at the UT MDACC laboratory, the system was connected to a 
computer that ran the calibration (Figure 7.3) and interface software (ASL) and saved the 
data, while another computer was used to display the images in a darkened room. In this 
setup, the subject was seated in the eye-tracker room equipped with monitoring facilities 
that allows communication with monitoring room. Images were displayed on a standard 
LCD monitor with 1024 by 768 pixels resolution using the Internet Explorer (Microsoft) 
browser. The raw data measured by the eye-tracker are the separation between the pupil 
center and the corneal reflection (CR). The relation between these raw values and the eye 
line of gaze differs for each subject and for different optical unit. The purpose of the 
calibration process is to provide data that will allow the eye-tracker to account for 
individual subject differences.  
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The objective is to have the subject look at (fixate on) each of the nine calibration 
points, which are at known locations. This procedure must be performed for every 
subject. The points are numbered from left to right; 1-3 for the top row, 4-6 for the 
middle row, and 7-9 for the bottom row. The actual distribution of the nine points is taken 
from the scene monitor and entered into memory with the eye-tracker “set target points” 
function. The points cover about 80 percent of the monitor screen area and are separated 
by 15-20 degrees visual angle horizontally and 10-15 degrees vertically. These are ideal 
specifications. The system was calibrated at the beginning of the session and repeated 







Figure 7.3: This image illustrates the calibration map image provided by the ASL eye-
tracker manufacture. The 9 points cover about 80 percent of the monitor screen area and 
are separated by 15-20 degrees visual angle horizontally and 10-15 degrees vertically. All 
points are numbered from left to right; 1-3 for the top row, 4-6 for the middle row, and 7-
9 for the bottom row. The blue dots indicate the gaze of the observer recorded during the 
calibration procedure. The observer was directed to start looking at from number 1and to 
proceed sequentially to number 9. Recalibration was performed as necessary. 
 
7.2.3 Data collection 
Eye-data were collected from two plastic surgeons who viewed clinical 
photographs of 8 women who underwent breast reconstruction. A web-based interface 
was used to display the clinical images and collect observer ratings of aesthetics (Chapter 
6) during the eye-tracker experiments (Figure 7.4). Five images of each patient are 
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displayed: an anterior-posterior and lateral and oblique views of both the right and left 
breasts. The oblique views are taken at an angle of about 45 degrees from the true lateral. 
The vertical extent of the views is from just below the chin down to the top of the pubic 
bone. The oblique views are taken at an angle of about 45 degrees from the true lateral. 
All images were displayed on a standard LCD monitor with 1024 by 768 pixels 
resolution using the Internet Explorer (© Microsoft Corporation) browser. 
Two plastic surgeons rated breast aesthetics using the top-six most influential 
rating items selected from a preliminary breast aesthetic rating instrument developed 
under the leadership of an experienced behavioral scientist Dr. Basen-Engquist  
(Behavioral Science, UT MDACC). The rating items used were: (1) initial impression of 
overall appearance of the breasts, (2) symmetry of size of breast mounds, (3) symmetry 
of shape of breast mounds, (4) aesthetic shape, (5) natural shape, and (6) final impression 
of overall appearance of the breasts (Refer to Chapter 6 for details on the rating items). A 
specific rating item is displayed before and after the images are displayed, but not while 
they are displayed to prevent the observer from being distracted by the rating item text. 
Vertical and horizontal coordinates of eye position and pupil diameter were saved to an 
“Eyedat file” on the Interface PC hard disk. In addition, event marks were entered from 
the keyboard to separate the recordings for each item. A field of data, consisting of the 
elements just listed, is recorded every 60th of a second (60 Hz update rate).    
 
7.2.4 Data analysis 
EyeNal and Fixplot (ASL, Bedford, MA) were used to plot and analyze the raw 
eye data on the images (Figure 7.4). Fixation is defined as the mean eye position over a 
minimum time period (0.1 sec) during which the gaze stays within 1 visual angle. Dwell 
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is defined as the amount of time during which a contiguous series of 1 or more fixations 
remains within a regions of interest (ROI). In this chapter, mean dwell times across rating 
items, patients, and observers were compared. I used the dwell time, rather than fixation 
time, because the latter is subject to more noise. The relationships between the eye-
position and the surgeons’ observer ratings were also analyzed.  
Regions of interests (ROIs) were used to further analyze the data. Two sets of 
regions were created, one for regions around each of the 5 photographic views (five 
ROIs), and another for regions around breast within the 5 photographic views (six ROIs): 
(1) left breast in AP view, (2) right breast in AP view, (3) both breasts in the left oblique 
view, (4) both breasts in the right oblique view, (5) left breast in the left lateral view, and 
(6) right breast in the right lateral view. Fixations were then plotted for each individual 
item with the regions of interest. Dwell-time tables and transition tables were analyzed. 
 
7.3 RESULTS 
7.3.1 Dwell time analysis 
Dwell time across the five views (an anterior-posterior and lateral and oblique 
views of both the right and left breasts) was analyzed and mean dwell time across rating 
items, patients, and observers were compared (Figure 7.4, Table 7.1). The average time 
that observer 1 (14.00 seconds) required to assess a case was about one and half times 
that of observer 2 (19.94 seconds), demonstrating that there is some inter-observer 
variability in how plastic surgeons approach this task (Table 7.1). Observer 1 spent more 
time on the items pertaining to shape than to the other items, whereas observer 2 spent 
the most time on the first item (initial impression of overall appearance) and less time on 
subsequent items. However, some consistent patterns in dwell time were also seen across 
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observers and cases. For example, both surgeons spent more time looking at the AP 
views than at the lateral and oblique views (Observer 1 54%, Observer 2 72%). 
Dwell time across the breast regions (separate regions in anterior-posterior and 
lateral and oblique views of both the right and left breasts) was analyzed and mean dwell 
time across rating items, patients, and observers were compared (Figure 7.5, Table 7.2). 
Results similar to those repeated in Table 7.1 were observed on time spent either across 
views or across items compared to the result in Table 7.1. When the dwell time was 
compared across the regions of breast, the results showed that both surgeons spent the 
most time on the breast regions in AP views, specifically more time on left breast regions 
than right breast region. Overall time spent across the patient cases reduced for both 
surgeons (O1: 94 sec, O2: 2min 82 sec). This can be explained by that the amount of 
dwells on other fiudcial points such as sternal notch or navel were removed as only breast 






Figure 7.4: This image illustrates an example of a visual scan path recorded by eye-
tracking equipment while an observer examined a case to rate the final impression of the 
overall appearance of the breasts. The observer rated this case as 9 on the 11-point scale, 
where 0 indicates very poor and 10 indicates excellent. It is apparent that the observer’s 
eyes dwelled longer on the AP view rather than on other views. The scan path also 
demonstrates that the observer’s eyes were drawn to the breast regions where surgical 
scars were present. Five images are displayed from each patient: an anterior-posterior 
(AP) and lateral and oblique views of both the right and left breasts. A specific item is 
displayed only before and after the images are displayed, but not while they are displayed 
to prevent the observer from being distracted by the item text. 
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Table 7.1: Mean dwell time across five views spent by two experienced plastic surgeons for assessing the outcomes of 8 
patients who underwent breast reconstruction. When dwell time was compared across the rating items, the results showed that 
observer 1 spent more time on the items pertaining to shape than on the other items, while observer 2 spent the most time on 
the first item (initial impression of overall impression) and spent less time on the subsequent items. When the dwell time was 
compared across the views, the results showed that both surgeons spent the most time on the AP views. Overall, observer 2 
spent more time evaluating a case than observer 1 did. The rating items are: (Item 1) initial impression of overall appearance of 
the breasts, (Item 2) symmetry of size of breast mounds, (Item 3) symmetry of shape of breast mounds, (Item 4) aesthetic 

















 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 
AP      1.84 2.74 1.56 2.16 1.76 1.58 1.88 2.15 1.68 1.02 1.34 1.19 10.07 10.84 72 54 
RL     0.15 0.89 0.09 0.39 0.29 0.28 0.20 0.39 0.35 0.42 0.08 0.25 1.17 2.61 8 13 
LL      0.05 0.22 0.08 0.22 0.14 0.57 0.19 0.30 0.12 0.43 0.11 0.05 0.69 1.78 5 9 
RO      0.21 0.78 0.18 0.38 0.26 0.41 0.12 0.52 0.24 0.09 0.10 0.15 1.12 2.34 8 12 
































































Figure 7.5: This image illustrates an example of a visual scan path recorded by eye-
tracking equipment while an observer 2 examined a case to rate the symmetry of size of 
breast mounds. Regions of interest were created around breast areas in each view. The 
observer rated this case as 7 on the 11-point scale, where 0 indicates very asymmetric and 
10 indicates very symmetric. The scan path demonstrates that the observer’s eyes were 
more drawn to the breast regions where surgical scars were present. Five images are 
displayed from each patient: an anterior-posterior (AP) and lateral and oblique views of 
both the right and left breasts. A specific breast aesthetics-related item is displayed only 
before and after the images are displayed to prevent the observer from being distracted by 







Table 7.2: Mean dwell time across breast regions spent by two experienced plastic surgeons for assessing the outcomes of 8 
patients who underwent breast reconstruction. Results similar to those repeated in Table 7.1 were observed. When the dwell 
time was compared across the regions of breast, the results showed that both surgeons spent the most time on the breast regions 

















 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 O1 O2 
 




4.27 30 25 
APLB 1.13 1.37 0.93 1.26 0.85 0.98 1.41 1.24 0.87 0.26 0.90 0.80 6.10 5.92 41 35 
RLB 0.35 0.44 0.21 0.20 0.49 0.22 0.54 0.27 0.45 0.28 0.08 0.00 2.13 1.40 14 8 
LLB 0.00 0.14 0.10 0.18 0.12 0.35 0.21 0.21 0.15 0.38 0.10 0.00 0.68 1.27 5 7 
ROB 0.22 0.70 0.00 0.37 0.07 0.46 0.19 0.45 0.11 0.05 0.08 0.14 0.67 2.17 4 13 
LOB 0.00 0.36 0.07 0.34 0.13 0.49 0.17 0.28 0.25 0.35 0.20 0.28 0.82 2.10 5 12 
Overall 
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7.3.1 Transitions frequency analysis 
A transition from region i to region j is defined as a dwell period in area i 
followed immediately by a dwell period in area j. I analyzed the frequency of transitions 
between breast regions in each view rather than broad regions of interest around each 
image view. The regions of interest used were: (APRB) patient’s right breast area in AP 
view, (APLB) patient’s left breast area in AP view, (ROB) patient breast area in right 
oblique view, (LOB) patient’s breast area in left oblique view, (RLB) patient’s right 
breast in right lateral view, (LLB) patient’s left breast in left lateral view (Figure 7.5). 
The average number of transitions between regions across the eight cases was computed 
for each observer for each item. In the transition martrices in Tables 7.3 – 7.8, the region 
given in the row label is the starting position and the region named in the column label is 
the ending position. 
When transitions between the regions were analyzed, some consistent patterns 
were seen across observers and rating items. The results showed that there were many 
high transitions between the breast regions in the AP view (APRB, APLB). The largest 
number of transitions was between regions APLB to region APRB for the both surgeons 
across the rating items. This trend was observed regardless of the type of rating items: 
both rating items for comparing symmetry between breasts (Table 7.4, Table 7.5) and 
individual ratings for the individual breast (Table 7.6, Table 7.7). Few transitions were 
observed between the oblique views, lateral views, or combinations of two. This result is 
consistent with our expectations that the surgeons primarily use the breast regions in AP 




Table 7.3: Mean transition activity across six regions of interest recorded, while an 
observer (GPR) examined 8 patients who underwent breast reconstruction case to rate the 
(Item 1) initial impression of overall appearance of the breasts. When transition was 
compared between the regions, the results showed that there were notably high transitions 
were observed pertaining breast regions in AP views (APRB, APLB). The highest 
transitional activity was from region APLB to region APRB for the both surgeons, O1 
(1.5) and O2 (1.3).  
 
APRB 
O1  O2 
APLB 
O1  O2 
ROB 
O1  O2 
LOB 
O1  O2 
RLB 
O1  O2 
LLB 
O1  O2 
APRB      0.0 0.0 0.9 0.9 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 
APLB      1.5 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 
ROB      0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 
LOB      0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 
RLB      0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 
LLB      0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 
 
 
Table 7.4: Mean transition activity across six regions of interest recorded, while an 
observer (GPR) examined 8 patients who underwent breast reconstruction case to rate the 
(Item 2) symmetry of size of breast mounds. When transition was compared between the 
regions, the results showed that there were notably high transitions were observed 
pertaining breast regions in AP views (APRB, APLB). The highest transitional activity 
was from region APLB to region APRB for the both surgeons, O1 (1.0), and O2 (1.3).  
 
APRB 
O1  O2 
APLB 
O1  O2 
ROB 
O1  O2 
LOB 
O1  O2 
RLB 
O1  O2 
LLB 
O1  O2 
APRB      0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
APLB      1.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
ROB      0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 
LOB      0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 
RLB      0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 





Table 7.5: Mean transition activity across six regions of interest recorded, while an 
observer (GPR) examined 8 patients who underwent breast reconstruction case to rate the 
(Item 3) symmetry of shape of breast mounds. When transition was compared between 
the regions, the results showed that there were notably high transitions were observed 
pertaining breast regions in AP views (APRB, APLB). The highest transitional activity 
was from region APLB to region APRB for the both surgeons, O1 (1.0), and O2 (0.5).  
 
APRB 
 O1  O2 
APLB 
 O1  O2 
ROB 
 O1  O2 
LOB 
 O1   O2 
RLB 
O1  O2 
LLB 
 O1  O2 
APRB      0.0 0.0 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
APLB      1.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
ROB      0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.4 0.1 0.0 0.0 
LOB      0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 
RLB      0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 
LLB      0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 
 
 
Table 7.6: Mean transition activity across six regions of interest recorded, while an 
observer (GPR) examined 8 patients who underwent breast reconstruction case to rate the 
(Item 4) aesthetic shape. When transition was compared between the regions, the results 
showed that there were notably high transitions were observed pertaining breast regions 
in AP views (APRB, APLB). The highest transitional activity was from region APLB to 
region APRB for the both surgeons, O1 (1.0), and O2 (1.0). 
 
APRB 
 O1   O2 
APLB 
 O1   O2 
ROB 
 O1   O2 
LOB 
 O1   O2 
RLB 
 O1   O2 
LLB 
 O1  O2 
APRB      0.0 0.0 0.9 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 
APLB      1.0 1.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 
ROB      0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 
LOB      0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 
RLB      0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 




Table 7.7: Mean transition activity across six regions of interest recorded, while an 
observer (GPR) examined 8 patients who underwent breast reconstruction case to rate the 
(Item 5) natural shape. When transition was compared between the regions, the results 
showed that there were notably high transitions were observed pertaining breast regions 
in AP views (APRB, APLB). The highest transitional activity was from region APLB to 
region APRB for surgeon, O1 (1.1), and from right breast area to left in oblique and 
lateral views for surgeon O2 (0.4). 
 
APRB 
O1  O2 
APLB 
O1  O2 
ROB 
O1  O2 
LOB 
O1  O2 
RLB 
O1  O2 
LLB 
O1  O2 
APRB      0.0 0.0 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
APLB      1.1 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 
ROB      0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 
LOB      0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 
RLB      0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 
LLB      0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 
 
 
Table 7.8: Mean transition activity across six regions of interest recorded, while an 
observer (GPR) examined 8 patients who underwent breast reconstruction case to rate the 
Q6 (Item 6) final impression of overall appearance of the breasts. When transition was 
compared between the regions, the results showed that there were notably high transitions 
were observed pertaining breast regions in AP views (APRB, APLB). The highest 
transitional activity was from region APLB to region APRB for surgeon, O1 (0.9), and 
from region APLB to region APRB for surgeon, O2 (0.5). 
 
APRB 
O1  O2 
APLB 
O1  O2 
ROB 
O1  O2 
LOB 
O1  O2 
RLB 
O1  O2 
LLB 
O1  O2 
APRB      0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
APLB      0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 
ROB      0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 
LOB      0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 
RLB      0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 




7.4 DISCUSSION AND CONCLUSION 
The goal of the study was to understand how plastic surgeons assess breast 
aesthetics by using eye-tracking technology to record their gaze path while they rate 
breast anatomy on clinical photographs. When the dwell time was compared across the 
views, the results showed that both surgeons spent the most time on the AP views. 
Similarly, when transition activity between regions was analyzed, there were many 
transitions observed between the breast regions in the AP view, while few transitions 
were observed between other views. This result is consistent with our expectations that 
the surgeons primarily use the breast regions in the AP view and move on to either 
oblique or lateral views if needed. One possible explanation for this trend of a great 
amount of time on and transitions between the breast regions in the AP view is that the 
eye is searching for asymmetry between the left and right breasts. 
 There are key limitations of this study on using eye-tracking for the assessment 
of aesthetic outcomes. First, even though extreme care was taken to control the 
experimental conditions, some inevitable variability was introduced because of 
uncontrollable variables such as technical difficulties and the physical condition of the 
subjects. The surgeons who participated in this study suffered from extreme fatigue that 
resulted in longer calibration time. Second, because of the limited number of observers 
and cases in this study, further investigations are needed. It is critical to repeat this study 
with different surgeons who were not aware of the patient cases used in this study to 
compare the results. 
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Chapter 8: DISCUSSION AND CONCLUSION  
8.1 SUMMARY OF WORK 
Our long-term goal is to develop decision aids that will improve breast cancer 
treatment. Quantitative, objective measures of aesthetic outcomes with high reliability are 
needed to meaningfully relate patient and surgical variables to aesthetic outcomes and to 
compare the outcomes of different breast cancer treatment strategies. 
In Chapter 2, I briefly review the literature on the various breast aesthetics 
outcome assessment methods currently used: subjective ratings, physical measurements, 
photographic measurements, and 3-D measurements. In Chapter 3, innovative 
quantitative, objective measurements of breast ptosis based on ratios of distances between 
fiducial points manually identified in lateral and oblique views of clinical photographs 
were proposed. I found that an existing subjective scale for rating ptosis showed high 
intra-observer agreement, but lower inter-observer agreement. New objective measures of 
ptosis showed encouraging levels of concordance with ratings made by experienced 
surgeons using the subjective scale. The objective measures were found to be robust to 
intra- and inter- observer variability in marking fiducial points, even when annotations by  
“novice” observers were used. In Chapter 4, I compared color measurements obtained by 
clinical digital photography to those from a standard colorimeter. I found that 
photography can be used in place of a colorimeter for measuring color properties of skin 
in a controlled setting. To investigate the validity of using photography for the 
assessment of scars, in Chapter 5, I presented results on using clinical photographs for the 
assessment of linear breast surgical scars. Digital clinical photographs were used to 
assess quantitative, objective measurements of breast surgical scars based on complete 
color intensity image analysis and area measurements. I demonstrated that the new 
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objective measures utilizing clinical photographs were effective. In Chapter 6, an 
observer rating scale of 11 symmetry ratings items, 14 individual breast ratings items, 
and a global rating on overall appearance before and after the entire rating items was 
proposed. The observer rating scale was assessed for intra- and inter-observer variability 
using rating data collected by reconstructive surgeons not involved in designing the scale.  
In Chapter 7, eye-data were collected from two plastic surgeons, while they rated breast 
aesthetics based on clinical photographs of 8 women who underwent breast 
reconstruction. Mean dwell time and transitions between regions of interest across rating 
items, patients, and observers were compared. Some consistent patterns in dwell time 
were seen across observers and cases. I found the results of the eye data recorded while 
the observer rated aesthetic qualities resembled that of the asymmetry search task 
investigated in other studies. 
 
8.2 SUGGESTIONS FOR FUTURE STUDIES 
As described in Chapter 2, breast cancer survivors face a myriad of choices to be 
made with the assistance of their multi-disciplinary breast care team. They must make 
decisions about surgical, radiation, chemotherapy, and endocrine therapy options. They 
must confront these issues with incomplete and, at times, contradictory information. A 
system for objective assessment of breast aesthetics is critical in order for breast cancer 
survivors to make right decisions for different reconstructive procedures. 
I have proposed quantitative outcome assessment methods using clinical 
photographs for two representative aesthetic features: ptosis and scars. Eye-tracking was 
used to understand how the surgeons assess the outcomes while they are looking at the 
clinical photographs. Substantial future work is needed, however, to fully quantitatively 
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understand breast outcomes and provide objective data to clinicians and breast cancer 
survivors. 
First, further development is needed to complete and validate a subjective but 
explicit observer rating scale to rate full range of breast aesthetics based on patients’ 
opinions as well as the knowledge of experienced reconstructive surgeons is needed. 
Both the observer rating scale and quantitative methods should be assessed for the intra- 
and inter-observer variability against each other using rating data collected by 
reconstructive surgeons and patients not involved in designing the scale.  
Second, image processing techniques to automatically locate the fiducial points 
should be developed. Previous studies have all used manually identified fiducial points 
by having a surgeon mark them when reviewing the images on a computer or photograph 
in print. One drawback to this approach is that reconstructive surgeons don’t routinely 
review the images in this manner and one needs to be cautious about developing medical 
decision aids that are dependent on clinicians performing tasks that aren’t a part of their 
normal workflow. A more fully automated system would be more practical to collect 
large data sets for outcome studies. Reconstructions using autologous tissue typically take 
4-12 hours and the most important decisions relating to breast shaping must be made 
towards the very end. Thus, an automated system would probably be necessary for any 
intra-operative analysis, since near real-time performance is needed. The automated 
system should be evaluated for the sensitivity of the algorithm for computing objective 
aesthetic measures against manual method for identifying fiducial points to improve the 
reliability. 
Third, 3D imaging should be explored since it has the potential to accurately 
measure aspects of breast anatomy that cannot be adequately evaluated using 2D 
imaging, such as curvature, shape, and volume. From one scan from a 3D camera, it is 
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possible to reconstruct an image of the breasts from any angle, whereas several standard 
photographs are needed to approximate the 3D nature of the breasts. However, current 
3D imaging systems are expensive and require a dedicated room in the clinic. Moreover, 
there has been little work to date on developing quantitative measures of breast aesthetics 
from 3D scans. Aesthetic outcome assessment methods used in 2D imaging should be 
extended to 3D imaging and the results should be compared to those obtained from 2D 
images. 
Finally, increased collaboration with behavioral scientists is needed to understand 
how patient satisfaction is related to aesthetics. Current studies have assessed the surgical 
outcomes by simply using the assessments either from clinicians, patients, or 
combination of two, but not integrating the aspects of behavioral science which can help 
clinicians understand patients’ assessments. In particular, expertise in body image would 
enhance our understanding of breast aesthetics and quality of life. 
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